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Abstract: The Forkead Box G1 (FOXG1) gene encodes for a DNA−binding 
transcription factor, essential for the development of the telencephalon 
in mammalian forebrain. Mutations in FOXG1 have been reported to be 
involved in the onset of Rett Syndrome, for which sequence alterations of 
MECP2 and CDKL5 are known. While visual alterations are not classical 
hallmarks of Rett syndrome, an increasing body of evidence shows visual 
impairment in patients and in MeCP2 and CDKL5 animal models. Herein we 
focused on the functional role of FOXG1 in the visual system of animal 
models (Foxg1+/Cre mice) and of a cohort of patients carrying FOXG1 
mutations or deletions. Visual physiology of Foxg1+/Cre mice was assessed 
by visually evoked potentials, which revealed a significant reduction in 
response amplitude and visual acuity with respect to wild-type 
littermates. Morphological investigation showed abnormalities in the 
organization of excitatory/inhibitory circuits in the visual cortex. No 
alterations were observed in retinal structure. By examining a cohort of 
FOXG1-mutated patients by means of a panel of neuro-ophthalmological 
evaluations, we found that all of them exhibited visual alterations 
compatible with high level visual dysfunctions. In conclusion our data 
show that Foxg1 haploinsufficiency results in an impairment of mouse and 
patient visual function. 
 
Response to Reviewers: Pisa February 27th 2016 
 
Dear Editor,  
 
We would like to thank the referees for the thoughtful critiques on our 
manuscript and for the opportunity to revise our work. Please find 
enclosed a revised version of our manuscript (NSC-15-1232) entitled 
“Visual impairment in FOXG1-mutated patients and mice” by Boggio et al.  
As requested, we performed additional experiments on retina and visual 
cortex in order to more quantitavely prove the structure specific 
alterations and strengthen our conclusions. We included below a detailed 
response to the reviewer comments (in italics). 
References have been updated and added as suggested by referees. 
 
 







1. The description of the morphology of the five classes of retinal 
neurons would benefit from a quantitative approach amenable to 
statistical comparisons, similar to that performed for cortical GABAergic 
neurons in Fig. 4. 
 
We performed the requested quantitative analysis that is now shown in 
fig. 4. The analysis was focussed on cells in the ganglion cell layer 
because this layer is known to be affected in Foxg1 null mice. No 
significant change in the overall number of cells, and in ganglion cells 
identified using the RBPMS cell type-specific antibody, was present in 
Foxg1 heterozygous mice  
 
 
2. There are no explicit statements regarding blinding of 
investigators to mouse genotypes during data acquisition and analyses, 
the use of Power Analysis to determine sample sizes, and predetermined 
criteria to exclude data sets. These are all critical issues that need to 
be performed and explicitly reported as recommended (Landis et al. Nature 
2012). 
 
We included in the methods the following section: 
 
Statistics and data collection. 
Data were collected and analyzed by investigators blind to the genetic 
and treatment status of the animal. Only animals with significantly 
altered EEG or breath rate during VEP recordings were discarded. Sample 
size was estimated by power analysis using data present in the literature 
on VEP and inhibitory circuit alterations in mouse models of 
neurodevelopmental disorders. Animals were randomly assigned to the 
various experimental groups caring that littermates were divided in the 
different experimental groups. To analyze data we used the paired t-test 
(to compare two repeated measures on the same subjects) and the t-test 
(to compare between different subjects). ANOVA was used to compare many 
groups. P=0.05 was assumed as significance level. Statistical analysis 





1. Ambulatory people should be referred to as "individuals", not 
"patients" because they are not hospitalized.  
 
We agree with the reviewer. The term patient was replaced by subject or 
individual along the entire paper. 
 
2. "Normal" and "abnormal" have negative connotations. "Typical" and 
"atypical" are preferred. 
 
 We agree with the reviewer and  the terms normal and abnormal  were 




3. "Mental retardation" has negative connotations. "Intellectual 
disability" is preferred.  
 
 Again, we agree with the reviewer and  “Mental retardation”  was 
replaced by “Intellectual disability”  along the entire paper. 
 
 
4. More details are needed about the acquisition and analysis of brain 
MRI, EEG, and VEP data from individuals with FOXG1 mutations and typical 
controls (for comparisons).  
 
We added a more complete description in the experimental procedures and 
in Table 1 legend. Morever we included the following paragraph in 
Results: 
 
Visual performance in control subjects  
All subjects with age older than 4 years showed a best corrected visual 
acuity between 20/20-20/25, color vision was 15/15 (Hishihara platelets), 
pupils were reactive, anterior segment and lenses were clear, fixation 
was stable and ocular motility was normal. Younger patients (age under 4 
years) showed a good engagement for near and far visual stimuli, they 
were able to follow light and objects and were also able to reach or 
grasp objects of interest even if presented in a crowded surrounding.VEPs 
results in control subjects showed a mean latency of the P100 of 99.19 
ms(range 90-105 ms); and a mean amplitude of the N75-P100 of 7,37 
µV(range 5-10,1 µV). 
 
 
5. More details are needed about the Foxg1-Cre heterozygous mice. For 
example, what does "Cre" means? Was the Foxg1 flanked by loxP sites 
("floxed") and deleted by breeding with a Cre-expressing mouse line? In 
what cell type was Cre expressed? Also, more clarity is needed on the 
mouse breeding scheme: were male WT cross with female Foxg1-Cre, or 
viceversa? 
 
We apologize for the lack of clarity and, as also requested by referee 2, 
these aspects are now described in the experimental procedure (animals) 
and in the results (section titled Reduced cortical VEP acuity in  Foxg1 
+/- Mice). 
In synthesis;  this mouse line was created by Herbert  et al (now quoted 
in the manuscript) to  facilitate genetic studies of telencephalic 
development by generating a mouse line, Foxg1–Cre, in which the sequence 
encoding the Cre recombinase is targeted to a locus expressed 
specifically in the telencephalon. The recombination pattern obtained 
with Foxg1–Cre mice matches the normal expression pattern of Foxg1, 
demonstrating the utility of this mouse for inducing tissue-specific 
recombination when  crosses with loxP mouse lines. 
 
 
6. The depth of the cortical electrode must be 100 microns, not 
nanometers. 
 
We apologize; the text has now been corrected.  
 
 
7. "O/N" should be spelled out. 
Done 
 
8. "Data not shown" should be presented. 
 






Reviewer #2: The results are interesting, however still preliminary. In 
brief the following points should be fully addressed before publication. 
 
1) In the human data there is no mention of analysis of age matched 
typically developing subjects. These control data are essential and 
should be provided. Given the wide range of ages analyzed, the small 
group of patients and complete lack of control subjects, and the complete 
lack of quantitative unbiased analysis (like VEP), the conclusions are at 
best anecdotal and should be tone down. 
 
Following the suggestions of the two referees we added a group of 20 age 
and sex matched control subjects who undergone a complete neuro-
ophthalmological exam and flash VEPs. Data of control subjects were 
included in the material and methods section and results. Moreover value 
of latency and amplitude of flash VEPs have been added in table 1 
including value of control subjects. 
 
 
2) In figure 1, the authors show a significant reduction in the visual 
acuity in Foxg1+/Cre mice. They claimed that there is a strong reduction 
of the VEP response also at the low spatial frequency (0.03-0.05 c/deg) 
but they don't show any waveform or any statistical analysis regarding 
such data. The wave form in response to low spatial frequency should be 
presented for the two genotypes and analysis of maximal amplitude and the 
latency performed and discussed.  
 
We agree with the referee. Waveforms are reported in fig. 1A and the 
stastistics of low-spatial frequency VEPs (0.1 c/deg) is reported in the 
results. 
 
3) Figure 4 is not well explained and contains several incongruences. 
The authors highlighted a significant reduction of NeuN density in the 
supragranular layers, whereas in the figure legends they don't report 
such result. In the figure legends, the authors talked about bins, 
whereas in figure 4 they used cell distribution as x axis title. It is 
also unclear how they could fit the same number of bins between the two 
genotypes or what do they mean with cell distribution. 
 
We agree that this analysis should be clarified. We have now recounted 
all our data based on cortical layers and added one mouse/group. Morever, 
we included the statistical analysis of NeuN density (Fig. 4 legend) and 
of cortical thickness (in the text of the Results).  
 
4) Based on the calbindin representative images (4D, left), this 
marker most likely stains also for pyramidal cells. How do the authors 
distinguish between the two cells population and make sure to quantify 
only the interneuron populations?  
 
Considering the observation made by the reviewer and data present in the 
literature calling into question the specificity of calbindin as an 
interneuronal marker we preferred to remove calbindin analysis from the 
paper and substitute it with the general inhibitory marker GAD67. 
 
 
5) Based on their NeuN cell density results, I would not had expected 
any major changed in sub-cell populations. Did the authors also quantify 
the overall number of interneurons with a GABA-GAD marker? What is it the 
cell density of the excitatory cells?  
 
We quantified the overall density of inhibitory interneurons by GAD67 
staining. No difference was present between genotype in any layer (Fig. 
5D). It has to be noted that the changes that we observed with calretinin 
and parvalbumin go in opposite direction possibly explaining the lack of 
change in the overall population of GAD67 positive cells. Considering 
that Neu-N is reduced significantly in the upper layers, we infer that 
the reduction is mostly due to a reduction in excitatory cells. 
 
 
6) In figure 5 the authors reported a reduction of spine density, 
however they should also report the overall cell morphology.  Is the 
spine density reduced due to shrinkage of the pyramidal cells following 
the shortening of the cortical layer? 
 
We checked cell diameter and no difference was present in cell body 
SEM 2.6; t-test p=0.76). 
 
 
7) Pag 12, line 60 :..consisting in a modestly thinner neocortex..". 
Looking at figure 4,  FoxG1+/Cre mice are characterized by a major 
shrinkage of the neocortex. Did the authors quantify cortical thickness 
across multiple sections/animals? 
 
Yes, there is a significantly thinner cortex (data in the Results 
section). This is prominently due to a reduction of layer II-III 
thickness associated with loss of Neu-N positive cells 
 
8) In the introduction the authors should discuss more in depth the 
function of the foxg1 protein or the fact that different mutations of the 
FOXG1 gene -microdeletion and microduplication- can induce different 
phenotypes in humans. For example, microdeletions and point mutations of  
FOXG1 gene, that usually result in a shortage of the protein, disrupt 
normal brain development causing brain malformation and severe 
developmental problems. Microduplications of the same gene have been 
identified in infants with West syndrome and are characterized by severe 
epilepsy. 
 
In the revised version of the manuscript we tried to better describe the 
FOXG1 congenital variant of Rett, as  a member of  the family of  FOXG1 




9)    The experimental procedures are poorly written and lack 
essential information. Info about the mouse model should be added in the 
animal section and clearly stated that the foxg1 Cre+/- mouse line is a 
knock-in line resulting in decrease of expression of FOXG1 gene. The 
relative citation should be provided in the main text and methods 
section. The authors should state how many mice, retinas, sections, cells 
have been used in each experiment reported. Right now it is a bit 
confusing and not totally clear (for example where the three retinas from 
3 mice or 2). Finally, in the immunohistochemistry section there is no 
information about acquisition parameters or quantification methods. How 
big are the bins for the interneurons analysis? How did the authors 
measure the spine density? per length of dendrite? How many spines, 
dendrites, cells did they count in each genotype? 
 
We agree with the reviewer and the experimental procedures  are now more 
detailed as requested. 
 
 
10) Overall the introduction and discussion are poorly written and lack 
major citations. For example, the authors should discuss the papers 
showing that RTT models have a specific visual phenotype, like in Tropea 
et al. 2009,  Durand et al., 2012; Krishnan et al., 2015 and the recently 
published LeBlanc et al. (Annals of Neurology 2015) reporting significant 
visual impairment in Rett Syndrome patients. Citations are also 
incomplete regarding disruption in interneuron circuits in Rett Syndrome. 
At a minimum, the authors should cite Durand et al., 2012, Tomassy et 
al., 2014 and Krishnan et al., 2015. 
 
The quotations have been updated including the reference pointed out by 
the referee, 
 
Minor points:  
The whole text contains several   for the mouse Foxg1 gene, human FOXG1 
gene, and related proteins throughout the paper.  
 
We clarified the nomenclature of Forkead BoxG1 (FOXG1in humans, Foxg1 in 
mice) gene in the abstract.  
 
The last paragraph of the introduction is repetitive and doesn't describe 
clearly the goals and/or the results of the present paper. 
 
We modified the paragraph according to the referee suggestion. 
 
Scale bars needs to be added to figure 4 and figure 5. 
 
Page 14, line 47-48: ".. PV immunoreactivity develops.. at P10..". Add a 
citation. It is usually believed that PV immunoreactivity in the visual 
cortex starts at eye opening, P12-P13. 
 
We thank the reviewer for making us notice this mistake. The text has now 
been corrected: 
PV immunoreactivity develops postnatally: in mice, it appears around eye 
opening at P13-P14 in intermediate layers, from which it expands to the 







Dear Editor,  
 
We would like to thank the referees for the thoughtful critiques on our manuscript and for the 
opportunity to revise our work. Please find enclosed a revised version of our manuscript (NSC-15-
1232) entitled “Visual impairment in FOXG1-mutated patients and mice” by Boggio et al.  
As requested, we performed additional experiments on retina and visual cortex in order to more 
quantitavely prove the structure specific alterations and strengthen our conclusions. We included 
below a detailed response to the reviewer comments (in italics). 
References have been updated and added as suggested by referees. 
This manuscript is in accordance with the Authorship statement of ethical standards for 
manuscripts submitted to Neuroscience. 
 








Dear Editor,  
 
We would like to thank the referees for the thoughtful critiques on our manuscript and for the 
opportunity to revise our work. Please find enclosed a revised version of our manuscript (NSC-15-
1232) entitled “Visual impairment in FOXG1-mutated patients and mice” by Boggio et al.  
As requested, we performed additional experiments on retina and visual cortex in order to more 
quantitavely prove the structure specific alterations and strengthen our conclusions. We included 
below a detailed response to the reviewer comments (in italics). 
References have been updated and added as suggested by referees. 
 
 







1. The description of the morphology of the five classes of retinal neurons 
would benefit from a quantitative approach amenable to statistical 
comparisons, similar to that performed for cortical GABAergic neurons in 
Fig. 4. 
 
We performed the requested quantitative analysis that is now shown in fig. 4. The analysis was 
focussed on cells in the ganglion cell layer because this layer is known to be affected in Foxg1 null 
mice. No significant change in the overall number of cells, and in ganglion cells identified using the 
RBPMS cell type-specific antibody, was present in Foxg1 heterozygous mice  
 
 
2. There are no explicit statements regarding blinding of investigators to 
mouse genotypes during data acquisition and analyses, the use of Power 
Analysis to determine sample sizes, and predetermined criteria to exclude 
data sets. These are all critical issues that need to be performed and 
explicitly reported as recommended (Landis et al. Nature 2012). 
 
We included in the methods the following section: 
 
Statistics and data collection. 
Data were collected and analyzed by investigators blind to the genetic and treatment status of the 
animal. Only animals with significantly altered EEG or breath rate during VEP recordings were 
discarded. Sample size was estimated by power analysis using data present in the literature on VEP 
and inhibitory circuit alterations in mouse models of neurodevelopmental disorders. Animals were 
*Response to Reviews
randomly assigned to the various experimental groups caring that littermates were divided in the 
different experimental groups. To analyze data we used the paired t-test (to compare two repeated 
measures on the same subjects) and the t-test (to compare between different subjects). ANOVA was 
used to compare many groups. P=0.05 was assumed as significance level. Statistical analysis was 





1. Ambulatory people should be referred to as "individuals", not 
"patients" because they are not hospitalized.  
 
We agree with the reviewer. The term patient was replaced by subject or individual along the entire 
paper. 
 
2. "Normal" and "abnormal" have negative connotations. "Typical" and 
"atypical" are preferred. 
 
 We agree with the reviewer and  the terms normal and abnormal  were replaced by typical and 
atypical along the entire paper when refer to human subjects. 
 
 
3. "Mental retardation" has negative connotations. "Intellectual 
disability" is preferred.  
 
 Again, we agree with the reviewer and  “Mental retardation”  was replaced by “Intellectual 
disability”  along the entire paper. 
 
 
4. More details are needed about the acquisition and analysis of 
brain MRI, EEG, and VEP data from individuals with FOXG1 mutations 
and typical controls (for comparisons).  
 
We added a more complete description in the experimental procedures and in Table 1 legend. 
Morever we included the following paragraph in Results: 
 
Visual performance in control subjects  
All subjects with age older than 4 years showed a best corrected visual acuity between 20/20-20/25, 
color vision was 15/15 (Hishihara platelets), pupils were reactive, anterior segment and lenses were 
clear, fixation was stable and ocular motility was normal. Younger patients (age under 4 years) 
showed a good engagement for near and far visual stimuli, they were able to follow light and 
objects and were also able to reach or grasp objects of interest even if presented in a crowded 
surrounding.VEPs results in control subjects showed a mean latency of the P100 of 99.19 ms(range 
90-105 ms); and a mean amplitude of the N75-P100 of 7,37 µV(range 5-10,1 µV). 
 
 
5. More details are needed about the Foxg1-Cre heterozygous mice. 
For example, what does "Cre" means? Was the Foxg1 flanked by loxP 
sites ("floxed") and deleted by breeding with a Cre-expressing mouse 
line? In what cell type was Cre expressed? Also, more clarity is 
needed on the mouse breeding scheme: were male WT cross with female 
Foxg1-Cre, or viceversa? 
 
We apologize for the lack of clarity and, as also requested by referee 2, these aspects are now 
described in the experimental procedure (animals) and in the results (section titled Reduced 
cortical VEP acuity in  Foxg1 +/- Mice). 
In synthesis;  this mouse line was created by Herbert  et al (now quoted in the manuscript) to 
facilitate genetic studies of telencephalic development by generating a mouse line, Foxg1–Cre, 
in which the sequence encoding the Cre recombinase is targeted to a locus expressed 
specifically in the telencephalon. The recombination pattern obtained with Foxg1–Cre mice 
matches the normal expression pattern of Foxg1, demonstrating the utility of this mouse for 
inducing tissue-specific recombination when  crosses with loxP mouse lines. 
 
 
6. The depth of the cortical electrode must be 100 microns, not 
nanometers. 
 
We apologize; the text has now been corrected.  
 
 
7. "O/N" should be spelled out. 
Done 
 
8. "Data not shown" should be presented. 
 





Reviewer #2: The results are interesting, however still preliminary. In brief 
the following points should be fully addressed before publication. 
 
1) In the human data there is no mention of analysis of age matched 
typically developing subjects. These control data are essential and 
should be provided. Given the wide range of ages analyzed, the small 
group of patients and complete lack of control subjects, and the complete 
lack of quantitative unbiased analysis (like VEP), the conclusions are at 
best anecdotal and should be tone down. 
 
Following the suggestions of the two referees we added a group of 20 age and sex matched 
control subjects who undergone a complete neuro-ophthalmological exam and flash VEPs. Data 
of control subjects were included in the material and methods section and results. Moreover 




2) In figure 1, the authors show a significant reduction in the 
visual acuity in Foxg1+/Cre mice. They claimed that there is a strong 
reduction of the VEP response also at the low spatial frequency (0.03-
0.05 c/deg) but they don't show any waveform or any statistical analysis 
regarding such data. The wave form in response to low spatial frequency 
should be presented for the two genotypes and analysis of maximal 
amplitude and the latency performed and discussed.  
 
We agree with the referee . Waveforms are reported in fig. 1A and the stastistics of low-spatial 
frequency VEPs (0.1 c/deg) is reported in the results. 
 
3) Figure 4 is not well explained and contains several incongruences. The 
authors highlighted a significant reduction of NeuN density in the 
supragranular layers, whereas in the figure legends they don't report 
such result. In the figure legends, the authors talked about bins, 
whereas in figure 4 they used cell distribution as x axis title. It 
is also unclear how they could fit the same number of bins between 
the two genotypes or what do they mean with cell distribution. 
 
We agree that this analysis should be clarified. We have now recounted all our data based on 
cortical layers and added one mouse/group. Morever, we included the statistical analysis of 
NeuN density (Fig. 4 legend) and of cortical thickness (in the text of the Results).  
 
4) Based on the calbindin representative images (4D, left), this marker 
most likely stains also for pyramidal cells. How do the authors 
distinguish between the two cells population and make sure to 
quantify only the interneuron populations?  
 
Considering the observation made by the reviewer and data present in the literature calling into 
question the specificity of calbindin as an interneuronal marker we preferred to remove 
calbindin analysis from the paper and substitute it with the general inhibitory marker GAD67. 
 
 
5) Based on their NeuN cell density results, I would not had expected any 
major changed in sub-cell populations. Did the authors also quantify 
the overall number of interneurons with a GABA-GAD marker? What is it 
the cell density of the excitatory cells?  
 
We quantified the overall density of inhibitory interneurons by GAD67 staining. No difference 
was present between genotype in any layer (Fig. 5D). It has to be noted that the changes that we 
observed with calretinin and parvalbumin go in opposite direction possibly explaining the lack 
of change in the overall population of GAD67 positive cells. Considering that Neu-N is reduced 




6) In figure 5 the authors reported a reduction of spine density, however 
they should also report the overall cell morphology.  Is the spine 
density reduced due to shrinkage of the pyramidal cells following the 
shortening of the cortical layer? 
 
We checked cell diameter and no difference was present in cell body diameter (wt N= 25 cells 
16.9 m SEM 2.3, Foxg1
+/Cre
 N=24 cells 15.8 m SEM 2.6; t-test p=0.76). 
 
 
7) Pag 12, line 60 :..consisting in a modestly thinner neocortex..". 
Looking at figure 4,  FoxG1+/Cre mice are characterized by a major 
shrinkage of the neocortex. Did the authors quantify cortical 
thickness across multiple sections/animals? 
 
Yes, there is a significantly thinner cortex (data in the Results section). This is prominently due 
to a reduction of layer II-III thickness associated with loss of Neu-N positive cells 
 
8) In the introduction the authors should discuss more in depth the 
function of the foxg1 protein or the fact that different mutations of 
the FOXG1 gene -microdeletion and microduplication- can induce 
different phenotypes in humans. For example, microdeletions and point 
mutations of  FOXG1 gene, that usually result in a shortage of the 
protein, disrupt normal brain development causing brain malformation 
and severe developmental problems. Microduplications of the same gene 
have been identified in infants with West syndrome and are 
characterized by severe epilepsy. 
 
In the revised version of the manuscript we tried to better describe the FOXG1 congenital 
variant of Rett, as  a member of  the family of  FOXG1 related disorder, also considering the 
space limitations imposed by the journal. 
 
 
9)    The experimental procedures are poorly written and lack essential 
information. Info about the mouse model should be added in the animal 
section and clearly stated that the foxg1 Cre+/- mouse line is a 
knock-in line resulting in decrease of expression of FOXG1 gene. The 
relative citation should be provided in the main text and methods 
section. The authors should state how many mice, retinas, sections, 
cells have been used in each experiment reported. Right now it is a 
bit confusing and not totally clear (for example where the three 
retinas from 3 mice or 2). Finally, in the immunohistochemistry 
section there is no information about acquisition parameters or 
quantification methods. How big are the bins for the interneurons 
analysis? How did the authors measure the spine density? per length 
of dendrite? How many spines, dendrites, cells did they count in each 
genotype? 
 





10)  Overall the introduction and discussion are poorly written and lack 
major citations. For example, the authors should discuss the papers 
showing that RTT models have a specific visual phenotype, like in 
Tropea et al. 2009,  Durand et al., 2012; Krishnan et al., 2015 and 
the recently published LeBlanc et al. (Annals of Neurology 2015) 
reporting significant visual impairment in Rett Syndrome patients. 
Citations are also incomplete regarding disruption in interneuron 
circuits in Rett Syndrome. At a minimum, the authors should cite 
Durand et al., 2012, Tomassy et al., 2014 and Krishnan et al., 2015. 
 
The quotations have been updated including the reference pointed out by the referee, 
 
Minor points:  
The whole text contains several   for the mouse Foxg1 gene, human FOXG1 gene, 
and related proteins throughout the paper.  
 
We clarified the nomenclature of Forkead Box G1 (FOXG1in humans, Foxg1 in mice) gene in the 
abstract.  
 
The last paragraph of the introduction is repetitive and doesn't describe 
clearly the goals and/or the results of the present paper. 
 
We modified the paragraph according to the referee suggestion. 
 
Scale bars needs to be added to figure 4 and figure 5. 
 
Page 14, line 47-48: ".. PV immunoreactivity develops.. at P10..". Add a 
citation. It is usually believed that PV immunoreactivity in the visual cortex 
starts at eye opening, P12-P13. 
 
We thank the reviewer for making us notice this mistake. The text has now been corrected: 
PV immunoreactivity develops postnatally: in mice, it appears around eye opening at P13-P14 in 






1) Foxg1 haploinsufficiency causes impairment of mouse and human visual function. 
 
2) Foxg1+/Cre mice show defects in the visual cortex excitatory/inhibitory circuits. 
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The Forkead Box G1 (FOXG1in humans, Foxg1 in mice) gene encodes for a DNA−binding 
transcription factor, essential for the development of the telencephalon in mammalian forebrain. 
Mutations in FOXG1 have been reported to be involved in the onset of Rett Syndrome, for which 
sequence alterations of MECP2 and CDKL5 are known. While visual alterations are not classical 
hallmarks of Rett syndrome, an increasing body of evidence shows visual impairment in patients 
and in MeCP2and CDKL5 animal models. Herein we focused on the functional role of FOXG1 in 
the visual system of animal models (Foxg1
+/Cre 
mice) and of a cohort of subjects carrying FOXG1 
mutations or deletions. Visual physiology of Foxg1
+/Cre 
mice was assessed by visually evoked 
potentials, which revealed a significant reduction in response amplitude and visual acuity with 
respect to wild-type littermates. Morphological investigation showed abnormalities in the 
organization of excitatory/inhibitory circuits in the visual cortex. No alterations were observed in 
retinal structure. By examining a cohort of FOXG1-mutated individuals with a panel of neuro-
ophthalmological assessments, we found that all of them exhibited visual alterations compatible 
with high level visual dysfunctions. In conclusion our data show that Foxg1 haploinsufficiency 
results in an impairment of mouse and human visual cortical function. 
 
 







































































Rett Syndrome (RTT) is a neurodevelopmental disorder representing one of the most common 
causes of intellectual disability in girls. Beside the classical form due to MECP2 mutations, two 
other forms have been associated to specific molecular defects, namely the early-onset seizure 
variant, mostly due to CDKL5 mutations, and the congenital variant, mostly due to FOXG1 
mutations. The association between the FOXG1 gene (OMIM#164874) and the congenital variant 
of RTT is relatively recent (Ariani et al., 2008), and since its discovery an increasing number of 
patients with FOXG1 point mutations have been reported. The human FOXG1 gene is located in the 
14q12 chromosome and encodes for a phylogenetically well conserved DNA-binding transcription 
factor of 489 aa. The mechanisms by which FOXG1 mutations cause RTT are still unknown, 
however the presence of FOXG1 on an autosomic chromosome suggests haploinsufficiency as a 
candidate for the aetio-pathological mechanisms of this RTT variant (Shoichet et al., 2005, De 
Filippis et al., 2012). Furthermore, a physical interaction between MeCP2 and FOXG1 has been 
demonstrated (Dastidar et al., 2012) suggesting that, at least in the Central Nervous system (CNS), 
an impairment in FOXG1-MeCP2 interaction could be critical for the development of RTT. 
Intriguingly, a recent report indicates that Foxg1 displays, together with a nuclear localization, a 
specific targeting to mitochondria. This finding sheds new light on the etiology of FOXG1-RTT and 
on the original mitochondrial dysfunction hypothesis for the RTT pathogenesis (Pancrazi et al., 
2015). 
Foxg1 presence is essential for the embryonic development of the telencephalon in mammalian 
forebrain (Xuan et al., 1995). Its expression is abundant since the early development, persisting at 
lower levels in the adult cortex including the visual areas (Shen et al., 2006). This pattern suggests 
that specific aspects of the RTT associated with FOXG1 mutations might involve visual cortical 
circuits. Foxg1 is also necessary for the correct formation of the inner ear and the olfactory system 
(Pauley et al., 2006, Duggan et al., 2008) and the appropriate crossing of retinal ganglion cell axons 
during development (Pratt et al., 2004). Interestingly, recent data show that Foxg1 overexpression is 
associated with neurodevelopmental pathologies and autism (Mariani et al., 2015). 
Foxg1 null mice were first obtained in 1995: while Foxg1
+/- 
animals were believed to have a normal 
phenotype, Foxg1
-/-
 mutants showed a dramatic reduction in the size of the cerebral hemispheres 
and died at birth. Due to the lethal phenotype, functional studies in null animals were initially 
restricted to the determination of the mechanisms influencing the forebrain size and the 
development of the telencephalon. More in depth analysis of the Foxg1
+/-
 model showed 
microcephaly, hyperlocomotion, impaired habituation in the open field and a severe deficit in 



































































FOXG1 expression such as the congenital variant of RTT and West syndrome (Shen et al., 2006, 
Eagleson et al., 2007, Siegenthaler et al., 2008). These features suggested the possibility to use 
Foxg1
+/- 
mutants as models for these diseases (Shen et al., 2006, Ariani et al., 2008, Bahi-Buisson et 
al., 2010, Mencarelli et al., 2010, Philippe et al., 2010, Le Guen et al., 2011a, Le Guen et al., 2011b, 
Striano et al., 2011, Tohyama et al., 2011).  
Recent work showed that the visual system is altered in mouse models of RTT (Tropea et al., 2009, 
Durand et al., 2012, Krishnan et al., 2015) providing the opportunity to use the visual system to 
investigate the patho-physiology of RTT and to improve objective patient evaluation. Indeed, a 
specific cortical processing deficit has been discovered using pattern reversal VEPs in RTT patients. 
Importantly, amplitude and latency of VEP waveforms are related to disease stage, clinical severity 
and MECP2 mutation (LeBlanc et al., 2015). The hypothesis that FOXG1 mutations affects visual 
development is also supported by data showing that in West syndrome patients, altered VEPs and 
poor visual behavior are hallmarks of the pathology (de Freitas Dotto et al., 2014). These data 
prompted us to analyze whether visual deficits were also present in Foxg1 RTT patients and in 
Foxg1
+/-
mice.  FOXG1 subject’s visual behavior suggested a high level visual dysfunction 
compatible with the blind-sight syndrome occurring in individuals with extensive damage of 
primary visual cortex and consisting in loss of awareness for visual stimuli. Similarly, mouse 
studies point to a severe alteration in the development of cortical inhibitory and excitatory 
circuits.The results of this study show that cortical visual impairments occur in both patients and 



































































Experimental procedures  
 
Subjects 
FOXG1 subjects: Eight subjects (5 females and 3 males) with a FOXG1 mutation were enrolled in 
the study. Age ranged from 9 months to 22 years (Table 1). All subjects had a clinical diagnosis of 
the congenital variant of RTT, with severe intellectual disability with early regression phase, severe 
microcephaly (range -3SD/-8SD) mostly postnatal, stereotypic handand tongue movements. One 
subject showed generalized epileptic seizures. Sleep disturbances were present in 5 out of 6 
individuals in whom the information was collected. Brain MRI was available for 6 cases. It was 
typical in one while the other 5 showed corpus callosum agenesis or hypoplasia and other brain 
asymmetries (Table 1). Menstrual disorders are not reported in the only girlin post-pubertal age 
(patient 8). 
Four subjects showed a 14q12 micro deletion involving the FOXG1 gene ranging in size from 
1.1Mb to 6.73Mb; four showed a point mutation predicted to lead to a truncation of the protein 
(Table 1). 
Controls were 20 subjects (10 males and 10 females, mean age 7.8 years;  range12 months-22 
years). None of them reported neurological problems, seizures, visual system diseases or history of 
pre- or perinatal illness. Subjects with refractive errors exceeding ± 1.5 diopters and strabismus 
were excluded. Regular neuro-ophthalmologic assessments were performed in each subject, 
including tests of visual acuity, color sensitivity, pupil reactivity, ocular alignment, fixation and 
motility, slit lamp evaluation, confrontation visual field testing, fundoscopy and recording of 
standard flash VEPs (Celesia, 1982, Lenassi et al., 2008). 
 
1) Patient clinical assessment: Genetic counseling and clinical assessment were performed for 5 out 
of 8 subjects by the same clinical geneticists (AR and MF) and child neuropsychiatrist (JH). 
Clinical data of the remaining 3 patients were collected through clinical reports provided bythe 
families (patients 1,2,5). 
 
2) Visual Assessment: Clinical neuro-ophthalmologic data of each subject, evaluated by an 
experienced neuro-ophthalmologist (AR),were collected, together with an extensive parents’ 
interview, specificfor visual abilities impairment. Patients were approached gradually by planning 
several sections of examination or observation. The following visual tests were performed: 
refractive errors measurement (by cycloplegia and correction with appropriate lenses); an estimate 



































































looking method); ocular alignment and fixation; oculo-cephalic reflexes; optokinetic nystagmus 
(when possible), cranial nerve examination; pupil reactivity evaluation; slit lamp examination; 
dilated fundoscopy. An estimation of visual field extension and subject’s interest towards colored or 
familial stimuli compared to unfamiliar or non-colored stimuli was obtained during the 
examination; finally, visual engagement and visual-manual coordination were also evaluated. 
Brain MRI, EEG and flash VEP datawere collected whenever the examination was possible.  
 
Animals 
The Foxg1-cre line was created by replacing the intron-less Foxg1 coding region (expressed 
specifically in the telencephalic cells)  with cre recombinase,  resulting in a Foxg1 heterozygous 
mouse with reduced expression of Foxg1 (Hebert and McConnell, 2000). 
Foxg1
+/Cre 
mice founders were a generous gift from Dr. Vania Broccoli. Animals were housed in a 
12-h light/dark cycle with free access to food and water. All the experiments were carried out in 
accordance with the directives the European Community Council (86/609/EEC) and approved by 
the Italian Ministry of Health. All mice used in this study were generated by heterozygous wild type 
matings of the original Foxg1
Cre
background (C57BL/6J)male with a wild type C57BL/6J  female. 
This breeding scheme was used since the heterozygous animals show behavioral abnormalities in 
the parental care. C57BL/6J (wild type) mice were purchased from the Jackson Laboratories (Bar 
Harbor, ME, USA).  
 
Statistics and data collection. 
Data were collected and analyzed by investigators blind to the genetic and treatment status of the 
animal. Only animals with significantly altered EEG or breath rate during VEP recordings were 
discarded. Sample size was estimated by power analysis using data present in the literature on VEP 
and inhibitory circuit alterations in mouse models of neurodevelopmental disorders. Animals were 
randomly assigned to the various experimental groups caring that littermates were divided in the 
different experimental groups. To analyze data we used the paired t-test (to compare two repeated 
measures on the same subjects) and the t-test (to compare between different subjects). ANOVA was 
used to compare many groups. P=0.05 was assumed as significance level. Statistical analysis was 
performed using the Sigma Stat (Systat, USA) software. 
 
 



































































Mice were anesthetized with an intraperitoneal injection of 20% urethane and mounted in a 
stereotaxic apparatus allowing a full view of the visual stimulus. After carefully removing a portion 
of the skull overlying the binocular visual cortex while leaving the dura mater intact, a glass-pulled 
recording electrode filled with NaCl (3 M) was inserted into the visual cortex perpendicularly to the 
stereotaxic plane. The electrode was inserted 100 m deep from pial surface and 2.7-3 mm lateral in 
correspondence to lambda. The electrical signals were amplified (10,000-fold), band-pass filtered 
(0.3–100 Hz), digitized, and averaged (at least 75 events in blocks of 5 each). The transient VEPs in 
response to an abrupt contrast reversal (1 Hz) were evaluated by measuring the peak-to-trough 
amplitude. The visual stimuli consisted of horizontal gratings of different spatial frequencies and 
contrasts generated by a visual stimulator interface (VSG2:2 card; Cambridge Research System, 
Cheshire, UK) and presented on a monitor (Sony model CPD-G520) placed 20 cm in front of the 
animal. 
 





Animals were deeply anaesthetized and perfused transcardially with PBS 1X followed by 4% 
paraformaldehyde. Brains were removed, post-fixed in the same fixative at 4°C and cryoprotected 
by immersion in 30% sucrose. Forty µm coronal sections were cut on a freezing microtome and 
processed for immunohistochemistry. Free floating sections were incubated for 1-2 hours in a 
blocking solution (10% BSA, 0,3% Triton X-100 in PBS), then in the primary antibody solution 
O/N. The following day, the sections were incubated with appropriate secondary antibodies, 
mounted on glass slides and acquired with a Leica TCS-SP confocal microscope. The images were  
analyzed with ImageJ software. The following primary Abs were used: NeuN (1:500; Millipore, 
Billerica, MA, USA), MeCP2 (1:1000 cat. n. M 9317 Sigma Aldrich, Germany), parvalbumin 
(1:1000, Sigma Aldrich, Germany), calretinin (1:1000, Swant, Switzerland) and GAD67 (1:500, 
Chemicon, USA). Secondary antibodies used were Alexa Fluor 488 and Alexa Fluor 555 from 
Invitrogen. 
 





Whole eyes were removed from deeply anesthetized mice (4 Foxg1
+/Cre 
and 4 wt mice), cut at the 
ora serrata and fixed for 1 hr in 4% paraformaldehyde. The anterior segments were removed, the 
eye cups rinsed in 0.1M phosphate buffer (PB), cryoprotected in 30% sucrose, infiltrated in OCT 
and snap frozen in isopentane/dry ice.  Afterwards, the eye cups were sectioned vertically at 12 µm 
on a Leica cryostat. The sections were collected on coated slides, processed for 



































































antibodies conjugated with Alexa Fluor 488 (from Invitrogen), Rodamine RedX or Cy3 (from 
Jackson). Selected sections were counterstained with micromolar solutions of Ethidium 
homodimer-1 or BOBO 1-iodide nuclear dyes (from Invitrogen). All preparations were screened 
with a Zeiss Axioplan microscope equipped with a colorAxioplan camera.  Selected sections were 
imaged at high resolution by confocal microscopy or with a Zeiss Apotome apparatus.  The 
following antibodies were used: for photoreceptors: rhodopsin (RET-P1Sigma #O4886) and cone-
specific L and M opsins (Millipore #AB5404 and #AB5407); for rod bipolar cells:  PKCα (Sigma 
#P4334);for selected cone bipolar cell types: synaptotagmin2 - ZNP1 (ZIRC, Zebrafish 
International Resource Center); for amacrine cells:calretinin (Swant #7699/4); for cholinergic 
amacrine cells:ChAT (Chemicon  #AB114P); for horizontal and ganglion cells:Neurofilament 200 
(Sigma  #N0142); for ganglion cells: SMI-32 (Covance#SMI32R) and Brn3 (Santa Cruz sc-6026); 
for synaptic ribbons: CtBP2 (Ribeye, BD Transduction Lab. #612044);for mitochondria: SOD2 
(Invitrogen#A21990). 
 





 mice were used for  counting cells in the ganglion cell 
layer (GCL) following published protocols (Damiani et al., 2012, Rodriguez et al., 2014). Briefly, 
paraformaldheyde fixed retinas (n=3 per strain, each from a different animal) were isolated from 
eye cups, the vitreous removed and 4 partial cuts made to delimitate the dorsal, nasal, ventral and 
temporal quadrants. After washes in 0.01M PBS, the retinas were blocked overnight at 4°C in a 
solution containing 0.5% Triton X-100 and 5% goat serum. Then, they were  incubated for 6 days at 
4°C with an anti-RNA binding protein (RBPMS), guinea pig antibody (Phospho Solutions, CO, 
USA), specific for GCs (diluted 1:500), with 1% serum and 0.1% Triton X-100. After 3x20’ 
washing in PBS, the retinas were incubated in Alexa Fluor 488-conjugated goat anti-guinea pig 
secondary antibody (Vector Laboratories, Burlingame, CA) diluted 1:800, washed 3x20’ in PBS 
and counterstained for 2 hrs with Ethidium homodimer 1 (Vector Laboratories), diluted 1:1,000. 
After washing, retinal samples were finally mounted “ganglion cells up” in Vectashield. Retinal 
profiles of whole mount preparations were imaged in bright field with an Axiocam camera attached 
to a Zeiss microscope, using a 1.25x objective. Retinal areas were then measured on image tiff files 
using the edge detector tool of a Metamorph® routine. Flat-mounted retinas were imaged with a 
Zeiss Apotome fluorescence microscope using a 40x/1.5 n.a. Plan Neofluar oil objective. Five focal 
series of images (each covering a retinal area of 224 x 168 µm) were acquired in each of the four 
retinal quadrants at regular intervals from the periphery towards the optic nerve head. Serial optical 



































































were than generated and used for counting separately RBPMS positive cells (labelled green) and the 
nuclei of all the neurons in the layer,  (labelled red), and comprising also those of  displaced 
amacrine cells. The nuclei of blood vessel cells were excluded based on their typical elongated 
shape, small size and high brightness. Serial optical sections  were used to count cells by navigating 
through z-stacks of the GCL in central retina areas characterized by elevated cell density.Total 
numbers of cells per retina were obtained multiplying average cellular densities by corresponding 
retinal areas. 
 
Dendritic spine analysis. 
Animals (n=3 for each genotype) were deeply anesthetized and perfused through the heart with 4% 
paraformaldehyde. A block of visual cortex was sectioned in the coronal plane into 300-μm-thick 
slices by using a vibratome. The lipophilic dye 1,1′-dioctadecyl-3,3,3′,3-
tetramethylindocarbocyanine (DiI) (Invitrogen) was coated onto tungsten particles (diameter 1.1 
μm; Bio-Rad) according to Gan et al. (Gan et al., 2000). DiI-coated particles were delivered to the 
slices by using a Helios Gene Gun System (Bio-Rad). A polycarbonate filter with a 3.0-μm pore 
size (Molecular Probes) was inserted between the gun and the preparation on a platform to remove 
clusters of large particles. Density of labeling was controlled by gas pressure (80 psi of helium). 
After labeling, slices were fixed in 4% paraformaldehyde. Labeled structures were analyzed 
by confocal microscopy. Images of basal dendrites of layer 2/3 pyramidal cells were acquired, 
stacked (0.5 μm step), and then analyzed with ImageJ.  A total of 49 cells were counted; at least 6 
dendrites per neuron were analyzed for a total number of 8820 spines. We measured the average 
spine lengths and densities (number of spines per length of dendrite) for each animal and calculated 





































































Visual performance in control subjects  
 
All subjects with age older than 4 years showed a best corrected visual acuity between 20/20-20/25, 
color vision was 15/15 (Hishihara platelets), pupils were reactive, anterior segment and lenses were 
clear, fixation was stable and ocular motility was normal. Younger patients (age under 4 years) 
showed a good engagement for near and far visual stimuli, they were able to follow light and 
objects and were also able to reach or grasp objects of interest even if presented in a crowded 
surrounding. VEPs results in control subjects showed a mean latency of the P100 of 99.19 ms(range 
90-105 ms); and a mean amplitude of the N75-P100 of 7,37 µV(range 5-10,1 µV). 
 
Visual impairment in patients with FOXG1 mutations 
Considering that West syndrome patients carrying unbalanced levels of FOXG1 show visual 
impairment and that RTT models show abnormal development and plasticity of the visual system 
(LeBlanc et al., 2015), we decided to investigate whether patients with FOXG1 mutations displayed 
visual atypicalities (Castano et al., 2000). In all patients (Table 1), visual attention and engagement 
worsened with fatigue both when observed during examination and as reported by parents. Patients 
were apparently receptive to near (within reaching) visual stimuli that captured their attention. 
Actually, bright colored stimuli and moving objects (particularly when presented at short distance) 
were preferred. Patients’ attention and awareness strongly decreased for far visual stimuli 
particularly when they were assembled with other objects (crowded surrounding). In these 
conditions, acoustic stimuli favored a brief visual engagement. Four patients out of eight 
demonstrated an inconstant ability to recognize familial faces (essentially parents), as observed 
during examination and reported by parents (Table 1). All patients had a variable dissociation 
between looking and reaching and demonstrated reduced or absent visual contact. All patients 
except one (#7) showed scarce visual engagement and no voluntary gazing toward surrounding 
visual stimuli. However, they were able to avoid obstacles or had a reaction of defense. They also 
showed an asymmetrical refractive defect between the two eyes. Four out of eight patients were 
photophobic and one showed compulsive gazing to bright light (#5). Anterior segment was typical 
in all patients. Pupils were reactive in seven out of eight cases. A jerk nystagmus was present in one 
patient (#2). Variable degrees of eyes misalignment and strabismus (exo and esotropia) were 
previously diagnosed in all patients. One patient presented a congenital oculomandibular syncinesia 



































































VEPs, performed in three out of eight patients, were in the range of controls (see table 1). EEG 
showed epileptic changes particularly in occipital parietal and temporal parietal regions in two 
patients. These data prompted us to further characterize visual impairment and uncover the 
underlying neural defects exploiting a mouse model of Foxg1 haploinsufficiency. 
 




To investigate possible consequences of the Foxg1 haploinsufficiency on visual function, we 
analyzed visual responses by recording Visually Evoked Potentials (VEP), a well-established 







) showing similar phenotype have been 
described in the literature (Shen et al., 2006, Eagleson et al., 2007). Among them, we choose the 
widely used Foxg1
+/Cre
 mice on a C57/BL6J background, which shows the most evident anatomical 
alterations of the cerebral cortex (Eagleson et al., 2007). Heterozygous mice were chosen because 
they better recapitulate the patient condition, insofar homozygous animals show birth lethality and a 
dramatic reduction in the size of the cerebral hemispheres.  
As expected, VEP responses to alternating gratings decreased in amplitude in response to 
increments of  the spatial frequency of the stimulus (Fig. 1). As shown in Fig. 1A, VEP transient 
amplitude is plotted against the spatial frequency log and visual acuity is taken as the spatial 
frequency that coincides with the extrapolation to zero amplitude of the linear regression. Visual 
acuity was significantly reduced in P30 Foxg1
+/Cre
 mice compared to wild-type littermates 
(Foxg1
+/Cre
, 0.20 +/- 0.05 cycles/degree, n=9; WT, 0.51 cycles/degree, n=5; *, P=0.01, t-test, Fig. 
1B). Moreover, VEP amplitudes at low spatial frequency were strongly diminished in  Foxg1
+/Cre
  
mice (0.1 c/deg, wt 166.3 V SEM 18.1, Foxg1
+/Cre
  18.1 V SEM4.6; t-test, p<0.001). These data 
suggest that FOXG1 mutations could result in visual impairments in mice as in humans. 
 
Retinal morphology in Foxg1
+/Cre 
and wt mice.  
 
To assess whether Foxg1 haploinsufficiency results into evident abnormalities in retinal 
morphological organization, we probed retinal sections of Foxg1
+/Cre
 mice and wild type littermates 
(n=3 per mice, per strain)  with a panel of antibodies, comprising well established cell-type specific 
markers, indicators of retinal lamination and constituents of retinal synaptic contacts (Jeon et al., 



































































Retinal neurons of all the five classes (photoreceptors, horizontal, bipolar, amacrine and ganglion 
cells), were labeled and compared among the two strains (Fig. 2, 3). None of the used retinal 
markers revealed obvious differences in the thickness of retinal layers, in their lamination pattern or 
in the morphology of individual cell types, between mutant and wt mice. Rhodopsin antibodies and 
ethidium nuclear staining highlighted a regular array of rod photoreceptors with no signs of 
degeneration (Fig.2, A-B). Cones displayed the normal, elongated morphology with outer segments 
of adequate length and orientation. Similarly, the main neurons of the retino-fugal (“vertical”) 
pathway, and namely rod bipolars (Fig. 3, A-B) and types of cone bipolars belonging to the “On” 
and “Off” functional varieties (C, D), had well ramified dendrites; their axonal arbors terminated in 
the appropriate sublaminae of the inner plexiform layer. Cholinergic processes, constituted by the 
dendrites of starburst amacrine cells, retained the characteristic distribution in two parallel bands 
precisely located at 1/3 and 2/3 of the inner plexiform layer (Fig.3, E and F). Calretinin staining 
revealed a third tier of processes, regularly positioned between the two cholinergic bands (Fig. 3, C 
and D). Ribeye, a marker of ribbons at retinal glutamatergic synapses (established by 
photoreceptors and bipolar cells) had the expected distribution in the outer and inner retina (Figure 
3, A and B). Particular attention was paid to the analysis of the morphology and the number of 
ganglion cells (GCs), known to display abnormalities in axonal projections in homozygous mice 
(Pratt et al., 2004, Tian et al., 2008). SMI-32 anti-neurofilament antibodies highlighted a tier of 
large-size cell bodies corresponding to alpha-like ganglion cells, while immunolabeling for Brn3B, 
the transcription factor selectively expressed in these neurons (Xiang et al., 1993) showed a similar 
pattern of nuclear staining in the ganglion cell layer (GCL) of mutant and control retinas (Fig.2 C-
D).  Similarly, immunostaining with 200 kDa neurofilament antibodies showed a regular 
arrangement of cell bodies in theGCL, the expected  bundles of axons in the optic fiber layer and 
profuse dendritic ramifications in the inner plexiform layer (Fig.3, E-F).The morphology of the 
optic nerve head in mutant mice appeared normal as well  (Fig.2 A).  
The GCL contains amacrine and ganglion cells, approximately in equal number in the rodent retina. 
Cell counts of retinal whole mounts (Fig. 4) from Foxg1
+/Cre 
(n=3 retinas) and Foxg1
+/+
 (wt) mice 
(n=3)  demonstrated that the two strains did not differ in the absolute number of cells in the GCL 
(Foxg1
+/Cre
 106300, SEM 5369; Foxg1
+/+
115475 cells SEM 4803, t-test; p=0.27; Fig.4 A-C). 
Selective counts of GCs, labeled with a RBPMS cell type-specific antibody, showed overlapping 
numbers of these neurons in mutant and wt strains (Fig.4 D). Noticeably, the numbers obtained here 
are not different from previously published data accounting for the total number of cells in the GCL 



































































In conclusion, no changes in general organization, architecture and pattern of lamination were 
observed in retinas of Foxg1
+/Cre
 mice, which appeared undistinguishable from those of their wt 
littermates. The heterozygous expression of FoxG1 does not affect the total number of cells in the 
innermost retinal layer. 
 
 
Morphological analysis of the visual cortex of Foxg1
+/Cre
 mice. 
Prompted by the strong functional impairment in cortical VEPs, we investigated the architecture of 
excitatory and inhibitory neurons in the visual cortex of Foxg1 haploinsufficient mice.  
As a general neuronal marker, we assessed the pattern of Neu-N immunostaining in P30 Foxg1
+/Cre 
mice. As already reported (Eagleson et al., 2007), the visual cortex is thinner in this line of 
mutants.(wt 914.3 m SEM 12.6;  Foxg1
+/Cre 
747.9 m SEM 29.8; n=4 for each group, t-test 
p=0.002).
 
To determine the occurrence of layer-specific effects of Foxg1 haploinsufficiency on 
neuronal density, we quantified Neu-N positive neurons along the cortical depth. As shown in Fig. 
5A, a significant reduction specific for layer II-III and layer IV was found in the mutant mice as 
compared to wt littermates.  
To assess whether morphological defects were associated with specific neuronal populations, we 
first studied markers of inhibitory interneurons since disruption in interneuron circuits has been 
found in RTT mouse models (Durand et al., 2012, Tomassy et al., 2014, Krishnan et al., 2015),  and 
then we investigated alterations in dendritic spines of excitatory pyramidal cells. 
 
Calretinin (CR), parvalbumin (PV) and GAD67 immunostaining.  Since maturation of cortical 
inhibition in visual areas is correlated with maturation of visual acuity and defects in cortical 
inhibition have been found in other mouse models of RTT (Dani et al., 2005, Lonetti et al., 2010), 
we decided to investigate the number of cortical inhibitory cells in Foxg1
+/Cre
 mice. Therefore, we 
estimated the density of CR, PVand GAD67 positive cells in the visual cortex at P30. CR 
immunostaining highlighted a significant increase in the interneuron density in the layers II-III and 
VI of the Foxg1
+/Cre 
cortex with respect to wt (Fig. 5B). By contrast, we observed a reduction of PV 
positive cell density in layers II-III of the visual cortex (Fig. 5C).  The total number of inhibitory 
cells calculated using GAD67 immunohistochemistry was not affected in heterozygous Foxg1
+/Cre
 
mice (Fig. 5D).  
 
Dendritic spine density and length. Alterations in density and size of dendritic spines have been 



































































also in many other models of neurodevelopmental disorders (Fiala et al., 2002). To investigate 
morphological alterations induced by Foxg1 haploinsufficiency, we evaluated by diolistic labeling  
the spine density and length in the basal dendrites of pyramidal cells (layer 2/3)  in visual cortices of 
Foxg1
+/Cre
 mice and wt littermates. As indicated in Fig. 6, no differences was present in spine 
length between the two genotypes (Fig. 6C) but a significant decrease in spine density was 
measured in Foxg1
+/Cre
 as compared to wt mice (Fig. 6B). No difference was present in cell body 
diameter (wt N= 25 cells 16.9 m SEM 2.3, Foxg1
+/Cre
 N=24 cells 15.8 m SEM 2.6; t-test 
p=0.76). 
These results indicate that the severe impairment of visual acuity caused by Foxg1 





In this report we demonstrate for the first time the functional consequences of Foxg1 
haploinsufficiency in the visual system of Foxg1
+/Cre
 mice and a visual impairment in a cohort of 
Rett individuals presenting genetic alteration on FOXG1. Previous reports showed minor alterations 
in haploinsufficent animals consisting in a modestly thinner neocortex and reduced dentate gyrus 
size.  To address this issue, we measured the visual acuity of Foxg1
+/Cre 
mice and their wild type 
littermates by means of Visually Evoked Potentials (VEPs). Our results show that Foxg1
+/Cre 
mice 
have a severe impairment in visual acuity and that the origin of such an impairment in visual 
function is not likely to reside in the retina, as retinal organization in these animals is normal.  
Indeed, retinal structure is qualitatively and quantitatively normal in Foxg1
+/Cre 
mice, and previous 
work showed that loss of a single Foxg1allele does not impair development of retinofugal axons 
(Tian et al., 2008). Consistently with the animal model, all the examined patients with FOXG1 
haploinsufficiency also show a visual impairment, with some common peculiarities. Such 




Visual alterations in FOXG1 mutated subjects 
 
A common visual behavior reported in these subjects by relatives is the apparent lack of interest for 



































































was better characterized in our subjects who mainly showed a scarce eye engagement, inconstant 
recognition of familial faces, and a general limited awareness to visual stimuli anywhere in the 
visual field, particularly when far and crowded. Despite a limited visual capacity, they were able to 
avoid obstacles and catch objects whenever positioned in neighboring space. The loss of attention 
and awareness for visual stimuli associated with the inability to disambiguate crowded objects or 
complex shapes; the inability of immediate recognition of familial faces, but the preserved interest 
and correct reaching or grasping toward colored stimuli and moving objects might suggest a 
condition resembling “blindsight”. Blindsight syndrome is a well-recognized neuro-
ophthalmological defect, which occurs upon extensive damage of the primary visual cortex (V1). 
Blindsight refers to the ability of cortically blind patients (bearing a primary visual cortex damage) 
to use extra striate visual information in guiding behaviors but in the absence of conscious object 
identification (Weiskrantz, 2009). Human blind-sight subjects are able to orient to and even answer 
questions about stimuli presented to the blind visual field. However, they are entirely unaware of 
the stimuli to which they are responding. Another characteristic of blindsight is that subjects can 
discriminate simple objects on the basis of their spatial frequency, shape, texture and color(Dineen 
and Keating, 1981), but they have lost the ability to identify more elaborate visual attributes, such 
as the capacity to visually recognize complex shapes or crowded objects, foods and familial faces. 
Moreover, blindsight patients well maintain reflexive saccades and motion perception, 
suggestingthat a residual network elaborating some visual information remains active even in case 
of extensive striate cortex lesions. The latter supports visually guided behaviors in the absence of 
awareness for visual stimuli. At least two separate pathways, and namely the retino-collicular and 
retino-geniculate pathways, reach the extrastriate cortex independently from the primary visual 
cortex, projecting to themotion area V5/MT in the medial temporal lobe. These connectionsmay 
represent theunconscious part of the dorsal ‘where’ visual stream, whereas the consciouscounterpart 
passes through the primary visual cortex before reachingthe V5/MT area. The extrastriate blind-
sight pathways could be active in the FOXG1 patients studied here, who indeed are attracted by 
colored and moving targets. On the contrary, their scarce awareness to visual stimuli might indicate 
a functional impairment of the striate visual pathway in the absence of retino-geniculate 
dysfunctions. This hypothesis (although not sustained by the demonstration of a structural damage 
of the occipital lobe detected by MRI) would suggest a functional impairment or incomplete 
maturation of the striate cortex as reinforced by the present results in the murine model.  
Another visual system change in the human subjects studied here is the occurrence of ocular 
malformations, such as strabismus, oculo-mandibular syncinesias and small optic discs. These 



































































callosum hypoplasia) may represent the expression of a global immaturity of the brain due to 
FOXG1 mutations.   
 




Retinal structure appeared normal in Foxg1
+/Cre
 mice, with no apparent anomalies  in cell type 
distribution,  laminar organization and numerical deficit in GCs that could explain the visual 
abnormalities On the contrary, morphological studies  showed significant changes in NeuN, PV and 
CR positive cells distribution in  the visual cortex of Foxg1
+/Cre 
mice compared to wild type 
animals. PV and CR are calcium binding proteins that serve as calcium buffers and label main 
subpopulations of GABA-ergic cortical interneurons. PV immunoreactivity develops postnatally: in 
mice, it appears around eye opening at P13-P14 in intermediate layers, from which it expands to the 
upper and inner cortical layers at subsequent developmental stages. In the visual cortex, PV positive 
cell maturation occurs during the critical period of ocular dominance plasticity and manipulations 
that accelerate or delay the time course of the critical period correspondingly regulate 
developmental maturation of PV cells. The decrease in PV cell density in uppermost layers and the 
increase in CR positive cells of Foxg1
+/Cre
cortex suggest that Foxg1 haploinsufficiency results in an 
impairment in inhibitory circuitry maturation. PV+ synapses are usually perisomatic and PV+ 
pattern of innervation of pyramidal cells is engaged in  controlof the spiking pattern. Their 
reciprocal and extensive connections can regulate the timing of activity in the cortex. Hence, we can 
speculate that the epileptic phenotype observed in FOXG1 mutated patients (Brunetti-Pierri et al., 
2011, Guerrini and Parrini, 2012) may be linked to a defective PV positive cells maturation. 
Conversely, CR positive cells usually synapse on dendrites; thus, the observed increase in CR 
positive cells in the lower layers of the Foxg1
+/Cre 
cortex may cause a local alteration in cortical 
inhibition. Intriguingly, analysis of GAD67 positive neurons showed that the total number of 
inhibitory cells is preserved in Foxg1
+/Cre
 mice. Thus, the reduction of NeuN positive neurons in the 
superficial layers is likely due to alterations of excitatory cells. 
To further analyze the excitatory phenotype in Foxg1
+/Cre 
primary visual cortex, we evaluated 
dendritic spine density and length in layer 2/3 pyramidal neurons. In the cerebral cortex, more than 
90% of excitatory synapses terminate on spines. Spine density in the mouse neocortex increases 
during the second and third week of life and is followed by a period of major spine pruning and 
loss. In the primary visual cortex, dendritic spine density and morphology are developmentally 



































































results demonstrate a decrease in spine density in Foxg1
+/Cre 
primary visual cortex compared to wild 
type animals.  
Altogether, these results suggest that Foxg1 haploinsufficiency causes alterations in both inhibitory 
and excitatory cells. Interestingly, alterations in inhibitory and excitatory synapses have been 
described in other mouse models of RTT as well as in a human disease model (iPSCs) obtained by 
genetic reprogramming of FOXG1-mutated patient fibroblasts (Patriarchi et al., 2015). In MeCP2-
KO animals, the cortical excitatory input is reduced whilst the total inhibitory input is enhanced, 
leading to a shift of the homeostatic balance between excitation and inhibition in favor of inhibition. 
Moreover, MeCP2-deficient cortical and hippocampal neurons have fewer dendritic spines. 
CDKL5, the other gene found mutated in some cases of RTT, codes for a protein that has been 
demonstrated to localize at excitatory synapses, where it contributes to correct dendritic spine 
structure and synapse activity. CDKL5 knockdown in cultured hippocampal neurons results in 
aberrant spine morphology (Chen et al., 2010) and unstable dendritic spines (Della Sala et al., 
2015). Intriguingly, the analysis of novel mouse models carrying Cdkl5 deletion showed alterations 
in sensory evoked potentials both in the auditory and the visual cortices (Wang et al., 2012, 
Amendola et al., 2014). 
In conclusion, Foxg1haploinsufficiency causes a severe impairment in visual function that is likely 
due to altered cortical mechanisms. This should be taken into account when Foxg1
+/Cre 
mice are 
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Legend to Figures  
 
Figure 1. Visual acuity in Foxg1
+/Cre 
 mice and wild-type littermates  
(A) Examples of VEP waveforms recorded in response to 0.1 c/deg gratings. (B) VEP amplitude 
changes in response to gratings of high contrast and of decreasing bar size (increasing spatial 
frequency) in a wild-type (WT) and a Foxg1
+/Cre 
mouse. VEP amplitude decreases by progressively 
increasing the spatial frequency. Visual acuity was determined by linearly extrapolating VEP 
amplitude to 0 V. Symbols represent data average data from all animals (WT n=9; Foxg1
+/Cre 
n=5). 
Arrows in the abscissa point to visual acuity value. Dotted line represents average noise level. (C) 
Spatial resolution in the visual cortex of wild-type and Foxg1
+/Cre
mice. Visual acuity is significantly 
reduced in Foxg1
+/Cre
mice compared with wild-type littermates (Foxg1
+/Cre
, 0.20 cycle/degree SEM 
0.05, n=9; WT, 0.51 cycle/degree, SEM 0.05 n=5; *, P,0.01, Student’s t test).  
 
Figure 2. Retinal morphology  in Foxg1
+/Cre
 animals and wild-type littermates 
Retinal morphology in Foxg1
+/Cre
 (A and C) and wt (B and D) mice. A, B: Low magnification 
images of retinal sections stained with rhodopsin antibodies (green signal), showing normal retinal 
laminations and bright staining of photoreceptor outer segments (OS) in both mutant and wt mice. 
Red: nuclear counterstaining. In A the normal morphology of the optic nerve head (ONH) can be 
appreciated. The insets show at 2x details of photoreceptor rows and outer segments. Here and in 
the following images: ONL, IPL outer nuclear and inner plexiform layer, respectively. C and D: 
examples of retinal ganglion cells (GC) stained by the type specific transcription factor Brn3-B 
(red), with nuclear localization, and by neurofilament antibodies (green), depicting their 
morphology in detail. 
 
Figure 3. Morphology of neuronal subtypes in Foxg1
+/Cre
 mice and wild-type littermates  
Morphology of retinal neuronal subtypes in Foxg1
+/Cre
 (left panels) and wt mice 
Retinal neurons in Foxg1
+/Cre
 (left panels) and wt mice. A, B: rod bipolar cells have been labelled 
red by PKC antibodies. Their dendrites form dense plexa in the OPL while axonal endings (rbe) 
cluster in regularly in the deepest part of the IPL. Green puncta are synaptic ribbons from 
glutamatergic processes, regularly arranged in the two plexiform layers. Blue: 
nuclearcounterstaining. C,D: types of cone bipolar cells stained by ZnP-1 (synaptotagmin 
antibodies). Both dendritic tips in the OPL and axonal arbors in the IPL have the expected fine 
structure. The IPL show three typical bands, revealed by calretinin staining of amacrine cells (red). 



































































symmetric populations at the two margins of the IPL. Alpha-like ganglion cells, labelled by SMI-32 
antibodies (green) have well preserved morphologies in both mutant and wt retinas. 
 





A,B. Cells in the GCL have been labelled by antibodies against the RNA binding protein RBPMS 
that produce a cytoplasmic staining in GCs selectively (green signal). Ethidium counterstaining (red 
signal) show the nuclei of GCs and displaced amacrine cells (AC).The general morphology (A and 





(B) mice. Quantification in C. The number of GCs proper (D) is also not different 
between the two strains (D). 
 





Panel A. A significant reduction of NeuN staining is present in layer II-III and IV of the visual 
cortex of Foxg1
+/Cre 
mice (WT: n=4; Foxg1
+/Cre
= n=4; two-ways RM ANOVA genotype X cortical 
layer p=0.003; post-hoc Sidak wt vs. Foxg1
+/Cre
 within layer II-III p=0.004, within layer IV 
p=0.006).  
Panel B. Calretinin positive cells in visual cortices from WT and Foxg1
+/Cre
 mice. Quantification of 
calretinin positive cells density in visual cortical layers of WT and Foxg1
+/Cre
 mice shows a 
significant increase of calretinin positive cells in layer II-III and VI of the Foxg1
+/Cre
 cortex (two-
ways RM ANOVA genotype X cortical layer p=0.04; post-hoc Sidak wt vs. Foxg1
+/Cre
 within layer 
II-III p<0.01, within layer VI p<0.05). 
Panel C Parvalbumin positive cells in visual cortices from WT and Foxg1
+/Cre 
mice. Quantification 
of parvalbumin positive cells density in visual cortical layers of WT and Foxg1
+/Cre
 mice shows a 
significant decrease of parvalbumin positive cells in layer II-III of the Foxg1
+/Cre
 cortex (two-ways 
RM ANOVA genotype X cortical layer p=0.03; post-hoc Sidak wt vs. Foxg1
+/Cre
 within layer II-III 
p<0.01).  
Panel D  GAD67 positive cells in visual cortices from WT and Foxg1
+/Cre 
mice. Quantification of 
GAD67 positive cells density in visual cortical layers of WT and Foxg1
+/Cre
 mice shows that the 
density of GAD67 positive cells is not statistically different between wt and Foxg1
+/Cre
 mice (two-
ways RM ANOVA effect of genotype p=0.44, genotype X cortical layer p=0.33)..*: p<0.05; **: 
p<0.01. 
 
Figure 6. Dendritic spine length and density in Foxg1
+/Cre



































































 A) Confocal microscope images of WT and Foxg1
+/Cre
dendritic segment. Scale bar= 5μm. B and 
C) Average dendritic spine length and density (respectively) in basal dendrites of layer 4/5 
pyramidal cells of Foxg1
+/Cre
and WT mice. A significant  decrease in spine density was measured 
in Foxg1
+/Cre
 as compared to wt mice (WT: n= 7; Foxg1
+/Cre
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The Forkead Box G1 (FOXG1in humans, Foxg1 in mice) gene encodes for a DNA−binding 
transcription factor, essential for the development of the telencephalon in mammalian forebrain. 
Mutations in FOXG1 have been reported to be involved in the onset of Rett Syndrome, for which 
sequence alterations of MECP2 and CDKL5 are known. While visual alterations are not classical 
hallmarks of Rett syndrome, an increasing body of evidence shows visual impairment in patients 
and in MeCP2and CDKL5 animal models. Herein we focused on the functional role of FOXG1 in 
the visual system of animal models (Foxg1
+/Cre 
mice) and of a cohort of subjects carrying FOXG1 
mutations or deletions. Visual physiology of Foxg1
+/Cre 
mice was assessed by visually evoked 
potentials, which revealed a significant reduction in response amplitude and visual acuity with 
respect to wild-type littermates. Morphological investigation showed abnormalities in the 
organization of excitatory/inhibitory circuits in the visual cortex. No alterations were observed in 
retinal structure. By examining a cohort of FOXG1-mutated individuals with a panel of neuro-
ophthalmological assessments, we found that all of them exhibited visual alterations compatible 
with high level visual dysfunctions. In conclusion our data show that Foxg1 haploinsufficiency 
results in an impairment of mouse and human visual cortical function. 
 
 







































































Rett Syndrome (RTT) is a neurodevelopmental disorder representing one of the most common 
causes of intellectual disability in girls. Beside the classical form due to MECP2 mutations, two 
other forms have been associated to specific molecular defects, namely the early-onset seizure 
variant, mostly due to CDKL5 mutations, and the congenital variant, mostly due to FOXG1 
mutations. The association between the FOXG1 gene (OMIM#164874) and the congenital variant 
of RTT is relatively recent (Ariani et al., 2008), and since its discovery an increasing number of 
patients with FOXG1 point mutations have been reported. The human FOXG1 gene is located in the 
14q12 chromosome and encodes for a phylogenetically well conserved DNA-binding transcription 
factor of 489 aa. The mechanisms by which FOXG1 mutations cause RTT are still unknown, 
however the presence of FOXG1 on an autosomic chromosome suggests haploinsufficiency as a 
candidate for the aetio-pathological mechanisms of this RTT variant (Shoichet et al., 2005, De 
Filippis et al., 2012). Furthermore, a physical interaction between MeCP2 and FOXG1 has been 
demonstrated (Dastidar et al., 2012) suggesting that, at least in the Central Nervous system (CNS), 
an impairment in FOXG1-MeCP2 interaction could be critical for the development of RTT. 
Intriguingly, a recent report indicates that Foxg1 displays, together with a nuclear localization, a 
specific targeting to mitochondria. This finding sheds new light on the etiology of FOXG1-RTT and 
on the original mitochondrial dysfunction hypothesis for the RTT pathogenesis (Pancrazi et al., 
2015). 
Foxg1 presence is essential for the embryonic development of the telencephalon in mammalian 
forebrain (Xuan et al., 1995). Its expression is abundant since the early development, persisting at 
lower levels in the adult cortex including the visual areas (Shen et al., 2006). This pattern suggests 
that specific aspects of the RTT associated with FOXG1 mutations might involve visual cortical 
circuits. Foxg1 is also necessary for the correct formation of the inner ear and the olfactory system 
(Pauley et al., 2006, Duggan et al., 2008) and the appropriate crossing of retinal ganglion cell axons 
during development (Pratt et al., 2004). Interestingly, recent data show that Foxg1 overexpression is 
associated with neurodevelopmental pathologies and autism (Mariani et al., 2015). 
Foxg1 null mice were first obtained in 1995: while Foxg1
+/- 
animals were believed to have a normal 
phenotype, Foxg1
-/-
 mutants showed a dramatic reduction in the size of the cerebral hemispheres 
and died at birth. Due to the lethal phenotype, functional studies in null animals were initially 
restricted to the determination of the mechanisms influencing the forebrain size and the 
development of the telencephalon. More in depth analysis of the Foxg1
+/-
 model showed 
microcephaly, hyperlocomotion, impaired habituation in the open field and a severe deficit in 
contextual fear conditioning, recapitulating some features of disorders derived from deregulation of 
Comment [M2]: “Mental retardation”  
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FOXG1 expression such as the congenital variant of RTT and West syndrome (Shen et al., 2006, 
Eagleson et al., 2007, Siegenthaler et al., 2008). These features suggested the possibility to use 
Foxg1
+/- 
mutants as models for these diseases (Shen et al., 2006, Ariani et al., 2008, Bahi-Buisson et 
al., 2010, Mencarelli et al., 2010, Philippe et al., 2010, Le Guen et al., 2011a, Le Guen et al., 2011b, 
Striano et al., 2011, Tohyama et al., 2011).  
Recent work showed that the visual system is altered in mouse models of RTT (Tropea et al., 2009, 
Durand et al., 2012, Krishnan et al., 2015) providing the opportunity to use the visual system to 
investigate the patho-physiology of RTT and to improve objective patient evaluation. Indeed, a 
specific cortical processing deficit has been discovered using pattern reversal VEPs in RTT patients. 
Importantly, amplitude and latency of VEP waveforms are related to disease stage, clinical severity 
and MECP2 mutation (LeBlanc et al., 2015). The hypothesis that FOXG1 mutations affects visual 
development is also supported by data showing that in West syndrome patients, altered VEPs and 
poor visual behavior are hallmarks of the pathology (de Freitas Dotto et al., 2014). These data 
prompted us to analyze whether visual deficits were also present in Foxg1 RTT patients and in 
Foxg1
+/-
mice.  FOXG1 subject’s visual behavior suggested a high level visual dysfunction 
compatible with the blind-sight syndrome occurring in individuals with extensive damage of 
primary visual cortex and consisting in loss of awareness for visual stimuli. Similarly, mouse 
studies point to a severe alteration in the development of cortical inhibitory and excitatory circuits. 
The results of this study show that cortical visual impairments occur in both patients and animal 



































































Experimental procedures  
 
Subjects 
FOXG1 subjects: Eight subjects (5 females and 3 males) with a FOXG1 mutation were enrolled in 
the study. Age ranged from 9 months to 22 years (Table 1). All subjects had a clinical diagnosis of 
the congenital variant of RTT, with severe intellectual disability with early regression phase, severe 
microcephaly (range -3SD/-8SD) mostly postnatal, stereotypic handand tongue movements. One 
subject showed generalized epileptic seizures. Sleep disturbances were present in 5 out of 6 
individuals in whom the information was collected. Brain MRI was available for 6 cases. It was 
typical in one while the other 5 showed corpus callosum agenesis or hypoplasia and other brain 
asymmetries (Table 1). Menstrual disorders are not reported in the only girlin post-pubertal age 
(patient 8). 
Four subjects showed a 14q12 micro deletion involving the FOXG1 gene ranging in size from 
1.1Mb to 6.73Mb; four showed a point mutation predicted to lead to a truncation of the protein 
(Table 1). 
Controls were 20 subjects (10 males and 10 females, mean age 7.8 years;  range12 months-22 
years). None of them reported neurological problems, seizures, visual system diseases or history of 
pre- or perinatal illness. Subjects with refractive errors exceeding ± 1.5 diopters and strabismus 
were excluded. Regular neuro-ophthalmologic assessments were performed in each subject, 
including tests of visual acuity, color sensitivity, pupil reactivity, ocular alignment, fixation and 
motility, slit lamp evaluation, confrontation visual field testing, fundoscopy and recording of 
standard flash VEPs (Celesia, 1982, Lenassi et al., 2008). 
 
1) Subjects Patient clinical assessment: Genetic counseling and clinical assessment were performed 
for 5 out of 8 subjects by the same clinical geneticists (AR and MF) and child neuropsychiatrist 
(JH). Clinical data of the remaining 3 patients were collected through clinical reports provided 
bythe families (patients 1,2,5). 
 
2) Visual Assessment: Clinical neuro-ophthalmologic data of each subject, evaluated by an 
experienced neuro-ophthalmologist (AR),were collected, together with an extensive parents’ 
interview, specificfor visual abilities impairment. Patients were approached gradually by planning 
several sections of examination or observation. The following visual tests were performed: 
refractive errors measurement (by cycloplegia and correction with appropriate lenses); an estimate 
of visual acuity and color vision (obtained using a modified form of forced choice-preferential 
Comment [M3]: terms normal and 
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looking method); ocular alignment and fixation; oculo-cephalic reflexes; optokinetic nystagmus 
(when possible), cranial nerve examination; pupil reactivity evaluation; slit lamp examination; 
dilated fundoscopy. An estimation of visual field extension and subject’s interest towards colored or 
familial stimuli compared to unfamiliar or non-colored stimuli was obtained during the 
examination; finally, visual engagement and visual-manual coordination were also evaluated. 
Brain MRI, EEG and flash VEP datawere collected whenever the examination was possible.  
 
Animals 
The Foxg1-cre line was created by replacing the intron-less Foxg1 coding region (expressed 
specifically in the telencephalic cells)  with cre recombinase,  resulting in a Foxg1 heterozygous 
mouse with reduced expression of Foxg1 (Hebert and McConnell, 2000). 
Foxg1
+/Cre 
mice founders were a generous gift from Dr. Vania Broccoli. Animals were housed in a 
12-h light/dark cycle with free access to food and water. All the experiments were carried out in 
accordance with the directives the European Community Council (86/609/EEC) and approved by 
the Italian Ministry of Health. All mice used in this study were generated by heterozygous wild type 
matings of the original Foxg1
Cre
background (C57BL/6J) male with a wild type C57BL/6J  female. 
This breeding scheme was used since the heterozygous animals show behavioral abnormalities in 
the parental care. C57BL/6J (wild type) mice were purchased from the Jackson Laboratories (Bar 
Harbor, ME, USA).  
 
Statistics and data collection. 
Data were collected and analyzed by investigators blind to the genetic and treatment status of the 
animal. Only animals with significantly altered EEG or breath rate during VEP recordings were 
discarded. Sample size was estimated by power analysis using data present in the literature on VEP 
and inhibitory circuit alterations in mouse models of neurodevelopmental disorders. Animals were 
randomly assigned to the various experimental groups caring that littermates were divided in the 
different experimental groups. To analyze data we used the paired t-test (to compare two repeated 
measures on the same subjects) and the t-test (to compare between different subjects). ANOVA was 
used to compare many groups. P=0.05 was assumed as significance level. Statistical analysis was 
performed using the Sigma Stat (Systat, USA) software. 
 
 



































































Mice were anesthetized with an intraperitoneal injection of 20% urethane and mounted in a 
stereotaxic apparatus allowing a full view of the visual stimulus. After carefully removing a portion 
of the skull overlying the binocular visual cortex while leaving the dura mater intact, a glass-pulled 
recording electrode filled with NaCl (3 M) was inserted into the visual cortex perpendicularly to the 
stereotaxic plane. The electrode was inserted 100 m deep from pial surface and 2.7-3 mm lateral in 
correspondence to lambda. The electrical signals were amplified (10,000-fold), band-pass filtered 
(0.3–100 Hz), digitized, and averaged (at least 75 events in blocks of 5 each). The transient VEPs in 
response to an abrupt contrast reversal (1 Hz) were evaluated by measuring the peak-to-trough 
amplitude. The visual stimuli consisted of horizontal gratings of different spatial frequencies and 
contrasts generated by a visual stimulator interface (VSG2:2 card; Cambridge Research System, 
Cheshire, UK) and presented on a monitor (Sony model CPD-G520) placed 20 cm in front of the 
animal. 
 





Animals were deeply anaesthetized and perfused transcardially with PBS 1X followed by 4% 
paraformaldehyde. Brains were removed, post-fixed in the same fixative at 4°C and cryoprotected 
by immersion in 30% sucrose. Forty µm coronal sections were cut on a freezing microtome and 
processed for immunohistochemistry. Free floating sections were incubated for 1-2 hours in a 
blocking solution (10% BSA, 0,3% Triton X-100 in PBS), then in the primary antibody solution 
over night  (O/N). The following day, the sections were incubated with appropriate secondary 
antibodies, mounted on glass slides and acquired with a Leica TCS-SP confocal microscope. The 
images were  analyzed with ImageJ software. The following primary Abs were used: NeuN (1:500; 
Millipore, Billerica, MA, USA), MeCP2 (1:1000 cat. n. M 9317 Sigma Aldrich, Germany), 
parvalbumin (1:1000, Sigma Aldrich, Germany), calretinin (1:1000, Swant, Switzerland) and GAD67 
(1:500, Chemicon, USA). Secondary antibodies used were Alexa Fluor 488 and Alexa Fluor 555 from 
Invitrogen. 
 





Whole eyes were removed from deeply anesthetized mice (4 Foxg1
+/Cre 
and 4 wt mice), cut at the 
ora serrata and fixed for 1 hr in 4% paraformaldehyde. The anterior segments were removed, the 
eye cups rinsed in 0.1M phosphate buffer (PB), cryoprotected in 30% sucrose, infiltrated in OCT 
and snap frozen in isopentane/dry ice.  Afterwards, the eye cups were sectioned vertically at 12 µm 
on a Leica cryostat. The sections were collected on coated slides, processed for 



































































antibodies conjugated with Alexa Fluor 488 (from Invitrogen), Rodamine RedX or Cy3 (from 
Jackson). Selected sections were counterstained with micromolar solutions of Ethidium 
homodimer-1 or BOBO 1-iodide nuclear dyes (from Invitrogen). All preparations were screened 
with a Zeiss Axioplan microscope equipped with a colorAxioplan camera.  Selected sections were 
imaged at high resolution by confocal microscopy or with a Zeiss Apotome apparatus.  The 
following antibodies were used: for photoreceptors: rhodopsin (RET-P1Sigma #O4886) and cone-
specific L and M opsins (Millipore #AB5404 and #AB5407); for rod bipolar cells:  PKCα (Sigma 
#P4334);for selected cone bipolar cell types: synaptotagmin2 - ZNP1 (ZIRC, Zebrafish 
International Resource Center); for amacrine cells:calretinin (Swant #7699/4); for cholinergic 
amacrine cells:ChAT (Chemicon  #AB114P); for horizontal and ganglion cells:Neurofilament 200 
(Sigma  #N0142); for ganglion cells: SMI-32 (Covance#SMI32R) and Brn3 (Santa Cruz sc-6026); 
for synaptic ribbons: CtBP2 (Ribeye, BD Transduction Lab. #612044);for mitochondria: SOD2 
(Invitrogen#A21990). 
 





 mice were used for  counting cells in the ganglion cell 
layer (GCL) following published protocols (Damiani et al., 2012, Rodriguez et al., 2014). Briefly, 
paraformaldheyde fixed retinas (n=3 per strain, each from a different animal) were isolated from 
eye cups, the vitreous removed and 4 partial cuts made to delimitate the dorsal, nasal, ventral and 
temporal quadrants. After washes in 0.01M PBS, the retinas were blocked overnight at 4°C in a 
solution containing 0.5% Triton X-100 and 5% goat serum. Then, they were  incubated for 6 days at 
4°C with an anti-RNA binding protein (RBPMS), guinea pig antibody (Phospho Solutions, CO, 
USA), specific for GCs (diluted 1:500), with 1% serum and 0.1% Triton X-100. After 3x20’ 
washing in PBS, the retinas were incubated in Alexa Fluor 488-conjugated goat anti-guinea pig 
secondary antibody (Vector Laboratories, Burlingame, CA) diluted 1:800, washed 3x20’ in PBS 
and counterstained for 2 hrs with Ethidium homodimer 1 (Vector Laboratories), diluted 1:1,000. 
After washing, retinal samples were finally mounted “ganglion cells up” in Vectashield. Retinal 
profiles of whole mount preparations were imaged in bright field with an Axiocam camera attached 
to a Zeiss microscope, using a 1.25x objective. Retinal areas were then measured on image tiff files 
using the edge detector tool of a Metamorph® routine. Flat-mounted retinas were imaged with a 
Zeiss Apotome fluorescence microscope using a 40x/1.5 n.a. Plan Neofluar oil objective. Five focal 
series of images (each covering a retinal area of 224 x 168 µm) were acquired in each of the four 
retinal quadrants at regular intervals from the periphery towards the optic nerve head. Serial optical 





































































were than generated and used for counting separately RBPMS positive cells (labelled green) and the 
nuclei of all the neurons in the layer,  (labelled red), and comprising also those of  displaced 
amacrine cells. The nuclei of blood vessel cells were excluded based on their typical elongated 
shape, small size and high brightness. Serial optical sections  were used to count cells by navigating 
through z-stacks of the GCL in central retina areas characterized by elevated cell density.Total 
numbers of cells per retina were obtained multiplying average cellular densities by corresponding 
retinal areas. 
 
Dendritic spine analysis. 
Animals (n=3 for each genotype) were deeply anesthetized and perfused through the heart with 4% 
paraformaldehyde. A block of visual cortex was sectioned in the coronal plane into 300-μm-thick 
slices by using a vibratome. The lipophilic dye 1,1′-dioctadecyl-3,3,3′,3-
tetramethylindocarbocyanine (DiI) (Invitrogen) was coated onto tungsten particles (diameter 1.1 
μm; Bio-Rad) according to Gan et al. (Gan et al., 2000). DiI-coated particles were delivered to the 
slices by using a Helios Gene Gun System (Bio-Rad). A polycarbonate filter with a 3.0-μm pore 
size (Molecular Probes) was inserted between the gun and the preparation on a platform to remove 
clusters of large particles. Density of labeling was controlled by gas pressure (80 psi of helium). 
After labeling, slices were fixed in 4% paraformaldehyde. Labeled structures were analyzed 
by confocal microscopy. Images of basal dendrites of layer 2/3 pyramidal cells were acquired, 
stacked (0.5 μm step), and then analyzed with ImageJ.  A total of 49 cells were counted; at least 6 
dendrites per neuron were analyzed for a total number of 8820 spines. We measured the average 
spine lengths and densities (number of spines per length of dendrite) for each animal and calculated 





































































Visual performance in control subjects  
 
All subjects with age older than 4 years showed a best corrected visual acuity between 20/20-20/25, 
color vision was 15/15 (Hishihara platelets), pupils were reactive, anterior segment and lenses were 
clear, fixation was stable and ocular motility was normal. Younger patients (age under 4 years) 
showed a good engagement for near and far visual stimuli, they were able to follow light and 
objects and were also able to reach or grasp objects of interest even if presented in a crowded 
surrounding. VEPs results in control subjects showed a mean latency of the P100 of 99.19 ms(range 
90-105 ms); and a mean amplitude of the N75-P100 of 7,37 µV(range 5-10,1 µV). 
 
Visual impairment in patients with FOXG1 mutations 
Considering that West syndrome patients carrying unbalanced levels of FOXG1 show visual 
impairment and that RTT models show abnormal development and plasticity of the visual system 
(LeBlanc et al., 2015), we decided to investigate whether patients with FOXG1 mutations displayed 
visual atypicalities (Castano et al., 2000). In all patients (Table 1), visual attention and engagement 
worsened with fatigue both when observed during examination and as reported by parents. Patients 
were apparently receptive to near (within reaching) visual stimuli that captured their attention. 
Actually, bright colored stimuli and moving objects (particularly when presented at short distance) 
were preferred. Patients’ attention and awareness strongly decreased for far visual stimuli 
particularly when they were assembled with other objects (crowded surrounding). In these 
conditions, acoustic stimuli favored a brief visual engagement. Four patients out of eight 
demonstrated an inconstant ability to recognize familial faces (essentially parents), as observed 
during examination and reported by parents (Table 1). All patients had a variable dissociation 
between looking and reaching and demonstrated reduced or absent visual contact. All patients 
except one (#7) showed scarce visual engagement and no voluntary gazing toward surrounding 
visual stimuli. However, they were able to avoid obstacles or had a reaction of defense. They also 
showed an asymmetrical refractive defect between the two eyes. Four out of eight patients were 
photophobic and one showed compulsive gazing to bright light (#5). Anterior segment was typical 
in all patients. Pupils were reactive in seven out of eight cases. A jerk nystagmus was present in one 
patient (#2). Variable degrees of eyes misalignment and strabismus (exo and esotropia) were 
previously diagnosed in all patients. One patient presented a congenital oculomandibular syncinesia 




































































VEPs, performed in three out of eight patients, were in the range of controls (see table 1). EEG 
showed epileptic changes particularly in occipital parietal and temporal parietal regions in two 
patients. These data prompted us to further characterize visual impairment and uncover the 
underlying neural defects exploiting a mouse model of Foxg1 haploinsufficiency. 
 




To investigate possible consequences of the Foxg1 haploinsufficiency on visual function, we 
analyzed visual responses by recording Visually Evoked Potentials (VEP), a well-established 







) showing similar phenotype have been 
described in the literature (Shen et al., 2006, Eagleson et al., 2007). Among them, we choose the 
widely used Foxg1
+/Cre
 mice on a C57/BL6J background, which shows the most evident anatomical 
alterations of the cerebral cortex (Eagleson et al., 2007). Heterozygous mice were chosen because 
they better recapitulate the patient condition, insofar homozygous animals show birth lethality and a 
dramatic reduction in the size of the cerebral hemispheres.  
As expected, VEP responses to alternating gratings decreased in amplitude in response to 
increments of  the spatial frequency of the stimulus (Fig. 1). As shown in Fig. 1A, VEP transient 
amplitude is plotted against the spatial frequency log and visual acuity is taken as the spatial 
frequency that coincides with the extrapolation to zero amplitude of the linear regression. Visual 
acuity was significantly reduced in P30 Foxg1
+/Cre
 mice compared to wild-type littermates 
(Foxg1
+/Cre
, 0.20 +/- 0.05 cycles/degree, n=9; WT, 0.51 cycles/degree, n=5; *, P=0.01, t-test, Fig. 
1B). Moreover, VEP amplitudes at low spatial frequency were strongly diminished in  Foxg1
+/Cre
  
mice (0.1 c/deg, wt 166.3 V SEM 18.1, Foxg1
+/Cre
  18.1 V SEM4.6; t-test, p<0.001). These data 
suggest that FOXG1 mutations could result in visual impairments in mice as in humans. 
 
Retinal morphology in Foxg1
+/Cre 
and wt mice.  
 
To assess whether Foxg1 haploinsufficiency results into evident abnormalities in retinal 
morphological organization, we probed retinal sections of Foxg1
+/Cre
 mice and wild type littermates 
(n=3 per mice, per strain)  with a panel of antibodies, comprising well established cell-type specific 
markers, indicators of retinal lamination and constituents of retinal synaptic contacts (Jeon et al., 



































































Retinal neurons of all the five classes (photoreceptors, horizontal, bipolar, amacrine and ganglion 
cells), were labeled and compared among the two strains (Fig. 2, 3). None of the used retinal 
markers revealed obvious differences in the thickness of retinal layers, in their lamination pattern or 
in the morphology of individual cell types, between mutant and wt mice. Rhodopsin antibodies and 
ethidium nuclear staining highlighted a regular array of rod photoreceptors with no signs of 
degeneration (Fig.2, A-B). Cones displayed the normal, elongated morphology with outer segments 
of adequate length and orientation. Similarly, the main neurons of the retino-fugal (“vertical”) 
pathway, and namely rod bipolars (Fig. 3, A-B) and types of cone bipolars belonging to the “On” 
and “Off” functional varieties (C, D), had well ramified dendrites; their axonal arbors terminated in 
the appropriate sublaminae of the inner plexiform layer. Cholinergic processes, constituted by the 
dendrites of starburst amacrine cells, retained the characteristic distribution in two parallel bands 
precisely located at 1/3 and 2/3 of the inner plexiform layer (Fig.3, E and F). Calretinin staining 
revealed a third tier of processes, regularly positioned between the two cholinergic bands (Fig. 3, C 
and D). Ribeye, a marker of ribbons at retinal glutamatergic synapses (established by 
photoreceptors and bipolar cells) had the expected distribution in the outer and inner retina (Figure 
3, A and B). Particular attention was paid to the analysis of the morphology and the number of 
ganglion cells (GCs), known to display abnormalities in axonal projections in homozygous mice 
(Pratt et al., 2004, Tian et al., 2008). SMI-32 anti-neurofilament antibodies highlighted a tier of 
large-size cell bodies corresponding to alpha-like ganglion cells, while immunolabeling for Brn3B, 
the transcription factor selectively expressed in these neurons (Xiang et al., 1993) showed a similar 
pattern of nuclear staining in the ganglion cell layer (GCL) of mutant and control retinas (Fig.2 C-
D).  Similarly, immunostaining with 200 kDa neurofilament antibodies showed a regular 
arrangement of cell bodies in theGCL, the expected  bundles of axons in the optic fiber layer and 
profuse dendritic ramifications in the inner plexiform layer (Fig.3, E-F).The morphology of the 
optic nerve head in mutant mice appeared normal as well  (Fig.2 A).  
The GCL contains amacrine and ganglion cells, approximately in equal number in the rodent retina. 
Cell counts of retinal whole mounts (Fig. 4) from Foxg1
+/Cre 
(n=3 retinas) and Foxg1
+/+
 (wt) mice 
(n=3)  demonstrated that the two strains did not differ in the absolute number of cells in the GCL 
(Foxg1
+/Cre
 106300, SEM 5369; Foxg1
+/+
115475 cells SEM 4803, t-test; p=0.27; Fig.4 A-C). 
Selective counts of GCs, labeled with a RBPMS cell type-specific antibody, showed overlapping 
numbers of these neurons in mutant and wt strains (Fig.4 D). Noticeably, the numbers obtained here 
are not different from previously published data accounting for the total number of cells in the GCL 



































































In conclusion, no changes in general organization, architecture and pattern of lamination were 
observed in retinas of Foxg1
+/Cre
 mice, which appeared undistinguishable from those of their wt 
littermates. The heterozygous expression of FoxG1 does not affect the total number of cells in the 
innermost retinal layer. 
 
 
Morphological analysis of the visual cortex of Foxg1
+/Cre
 mice. 
Prompted by the strong functional impairment in cortical VEPs, we investigated the architecture of 
excitatory and inhibitory neurons in the visual cortex of Foxg1 haploinsufficient mice.  
As a general neuronal marker, we assessed the pattern of Neu-N immunostaining in P30 Foxg1
+/Cre 
mice. As already reported (Eagleson et al., 2007), the visual cortex is thinner in this line of 
mutants.(wt 914.3 m SEM 12.6;  Foxg1
+/Cre 
747.9 m SEM 29.8; n=4 for each group, t-test 
p=0.002).
 
To determine the occurrence of layer-specific effects of Foxg1 haploinsufficiency on 
neuronal density, we quantified Neu-N positive neurons along the cortical depth. As shown in Fig. 
5A, a significant reduction specific for layer II-III and layer IV was found in the mutant mice as 
compared to wt littermates.  
To assess whether morphological defects were associated with specific neuronal populations, we 
first studied markers of inhibitory interneurons since disruption in interneuron circuits has been 
found in RTT mouse models (Durand et al., 2012, Tomassy et al., 2014, Krishnan et al., 2015),  and 
then we investigated alterations in dendritic spines of excitatory pyramidal cells. 
 
Calretinin (CR), parvalbumin (PV) and GAD67 immunostaining.  Since maturation of cortical 
inhibition in visual areas is correlated with maturation of visual acuity and defects in cortical 
inhibition have been found in other mouse models of RTT (Dani et al., 2005, Lonetti et al., 2010), 
we decided to investigate the number of cortical inhibitory cells in Foxg1
+/Cre
 mice. Therefore, we 
estimated the density of CR, PVand GAD67 positive cells in the visual cortex at P30. CR 
immunostaining highlighted a significant increase in the interneuron density in the layers II-III and 
VI of the Foxg1
+/Cre 
cortex with respect to wt (Fig. 5B). By contrast, we observed a reduction of PV 
positive cell density in layers II-III of the visual cortex (Fig. 5C).  The total number of inhibitory 
cells calculated using GAD67 immunohistochemistry was not affected in heterozygous Foxg1
+/Cre
 
mice (Fig. 5D).  
 
Dendritic spine density and length. Alterations in density and size of dendritic spines have been 



































































also in many other models of neurodevelopmental disorders (Fiala et al., 2002). To investigate 
morphological alterations induced by Foxg1 haploinsufficiency, we evaluated by diolistic labeling  
the spine density and length in the basal dendrites of pyramidal cells (layer 2/3)  in visual cortices of 
Foxg1
+/Cre
 mice and wt littermates. As indicated in Fig. 6, no differences was present in spine 
length between the two genotypes (Fig. 6C) but a significant decrease in spine density was 
measured in Foxg1
+/Cre
 as compared to wt mice (Fig. 6B). No difference was present in cell body 
diameter (wt N= 25 cells 16.9 m SEM 2.3, Foxg1
+/Cre
 N=24 cells 15.8 m SEM 2.6; t-test 
p=0.76). 
These results indicate that the severe impairment of visual acuity caused by Foxg1 





In this report we demonstrate for the first time the functional consequences of Foxg1 
haploinsufficiency in the visual system of Foxg1
+/Cre
 mice and a visual impairment in a cohort of 
Rett individuals presenting genetic alteration on FOXG1. Previous reports showed minor alterations 
in haploinsufficent animals consisting in a modestly thinner neocortex and reduced dentate gyrus 
size.  To address this issue, we measured the visual acuity of Foxg1
+/Cre 
mice and their wild type 
littermates by means of Visually Evoked Potentials (VEPs). Our results show that Foxg1
+/Cre 
mice 
have a severe impairment in visual acuity and that the origin of such an impairment in visual 
function is not likely to reside in the retina, as retinal organization in these animals is normal.  
Indeed, retinal structure is qualitatively and quantitatively normal in Foxg1
+/Cre 
mice, and previous 
work showed that loss of a single Foxg1allele does not impair development of retinofugal axons 
(Tian et al., 2008). Consistently with the animal model, all the examined  subjects with FOXG1 
haploinsufficiency also show a visual impairment, with some common peculiarities. Such 




Visual alterations in FOXG1 mutated subjects 
 
A common visual behavior reported in these subjects by relatives is the apparent lack of interest for 



































































was better characterized in our subjects who mainly showed a scarce eye engagement, inconstant 
recognition of familial faces, and a general limited awareness to visual stimuli anywhere in the 
visual field, particularly when far and crowded. Despite a limited visual capacity, they were able to 
avoid obstacles and catch objects whenever positioned in neighboring space. The loss of attention 
and awareness for visual stimuli associated with the inability to disambiguate crowded objects or 
complex shapes; the inability of immediate recognition of familial faces, but the preserved interest 
and correct reaching or grasping toward colored stimuli and moving objects might suggest a 
condition resembling “blindsight”. Blindsight syndrome is a well-recognized neuro-
ophthalmological defect, which occurs upon extensive damage of the primary visual cortex (V1). 
Blindsight refers to the ability of cortically blind patients (bearing a primary visual cortex damage) 
to use extra striate visual information in guiding behaviors but in the absence of conscious object 
identification (Weiskrantz, 2009). Human blind-sight subjects are able to orient to and even answer 
questions about stimuli presented to the blind visual field. However, they are entirely unaware of 
the stimuli to which they are responding. Another characteristic of blindsight is that subjects can 
discriminate simple objects on the basis of their spatial frequency, shape, texture and color (Dineen 
and Keating, 1981), but they have lost the ability to identify more elaborate visual attributes, such 
as the capacity to visually recognize complex shapes or crowded objects, foods and familial faces. 
Moreover, blindsight patients well maintain reflexive saccades and motion perception, 
suggestingthat a residual network elaborating some visual information remains active even in case 
of extensive striate cortex lesions. The latter supports visually guided behaviors in the absence of 
awareness for visual stimuli. At least two separate pathways, and namely the retino-collicular and 
retino-geniculate pathways, reach the extrastriate cortex independently from the primary visual 
cortex, projecting to themotion area V5/MT in the medial temporal lobe. These connectionsmay 
represent theunconscious part of the dorsal ‘where’ visual stream, whereas the consciouscounterpart 
passes through the primary visual cortex before reachingthe V5/MT area. The extrastriate blind-
sight pathways could be active in the FOXG1 patients studied here, who indeed are attracted by 
colored and moving targets. On the contrary, their scarce awareness to visual stimuli might indicate 
a functional impairment of the striate visual pathway in the absence of retino-geniculate 
dysfunctions. This hypothesis (although not sustained by the demonstration of a structural damage 
of the occipital lobe detected by MRI) would suggest a functional impairment or incomplete 
maturation of the striate cortex as reinforced by the present results in the murine model.  
Another visual system change in the human subjects studied here is the occurrence of ocular 
malformations, such as strabismus, oculo-mandibular syncinesias and small optic discs. These 



































































callosum hypoplasia) may represent the expression of a global immaturity of the brain due to 
FOXG1 mutations.   
 




Retinal structure appeared normal in Foxg1
+/Cre
 mice, with no apparent anomalies  in cell type 
distribution,  laminar organization and numerical deficit in GCs that could explain the visual 
abnormalities. On the contrary, morphological studies  showed significant changes in NeuN, PV 
and CR positive cells distribution in  the visual cortex of Foxg1
+/Cre 
mice compared to wild type 
animals. PV and CR are calcium binding proteins that serve as calcium buffers and label main 
subpopulations of GABA-ergic cortical interneurons. PV immunoreactivity develops postnatally: in 
mice, it appears around eye opening at P13-P14 in intermediate layers, from which it expands to the 
upper and inner cortical layers at subsequent developmental stages. In the visual cortex, PV positive 
cell maturation occurs during the critical period of ocular dominance plasticity and manipulations 
that accelerate or delay the time course of the critical period correspondingly regulate 
developmental maturation of PV cells. The decrease in PV cell density in uppermost layers and the 
increase in CR positive cells of Foxg1
+/Cre
cortex suggest that Foxg1 haploinsufficiency results in an 
impairment in inhibitory circuitry maturation. PV+ synapses are usually perisomatic and PV+ 
pattern of innervation of pyramidal cells is engaged in  controlof the spiking pattern. Their 
reciprocal and extensive connections can regulate the timing of activity in the cortex. Hence, we can 
speculate that the epileptic phenotype observed in FOXG1 mutated patients (Brunetti-Pierri et al., 
2011, Guerrini and Parrini, 2012) may be linked to a defective PV positive cells maturation. 
Conversely, CR positive cells usually synapse on dendrites; thus, the observed increase in CR 
positive cells in the lower layers of the Foxg1
+/Cre 
cortex may cause a local alteration in cortical 
inhibition. Intriguingly, analysis of GAD67 positive neurons showed that the total number of 
inhibitory cells is preserved in Foxg1
+/Cre
 mice. Thus, the reduction of NeuN positive neurons in the 
superficial layers is likely due to alterations of excitatory cells. 
To further analyze the excitatory phenotype in Foxg1
+/Cre 
primary visual cortex, we evaluated 
dendritic spine density and length in layer 2/3 pyramidal neurons. In the cerebral cortex, more than 
90% of excitatory synapses terminate on spines. Spine density in the mouse neocortex increases 
during the second and third week of life and is followed by a period of major spine pruning and 
loss. In the primary visual cortex, dendritic spine density and morphology are developmentally 



































































results demonstrate a decrease in spine density in Foxg1
+/Cre 
primary visual cortex compared to wild 
type animals.  
Altogether, these results suggest that Foxg1 haploinsufficiency causes alterations in both inhibitory 
and excitatory cells. Interestingly, alterations in inhibitory and excitatory synapses have been 
described in other mouse models of RTT as well as in a human disease model (iPSCs) obtained by 
genetic reprogramming of FOXG1-mutated patient fibroblasts (Patriarchi et al., 2015). In MeCP2-
KO animals, the cortical excitatory input is reduced whilst the total inhibitory input is enhanced, 
leading to a shift of the homeostatic balance between excitation and inhibition in favor of inhibition. 
Moreover, MeCP2-deficient cortical and hippocampal neurons have fewer dendritic spines. 
CDKL5, the other gene found mutated in some cases of RTT, codes for a protein that has been 
demonstrated to localize at excitatory synapses, where it contributes to correct dendritic spine 
structure and synapse activity. CDKL5 knockdown in cultured hippocampal neurons results in 
aberrant spine morphology (Chen et al., 2010) and unstable dendritic spines (Della Sala et al., 
2015). Intriguingly, the analysis of novel mouse models carrying Cdkl5 deletion showed alterations 
in sensory evoked potentials both in the auditory and the visual cortices (Wang et al., 2012, 
Amendola et al., 2014). 
In conclusion, Foxg1haploinsufficiency causes a severe impairment in visual function that is likely 
due to altered cortical mechanisms. This should be taken into account when Foxg1
+/Cre 
mice are 
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Legend to Figures  
 
Figure 1. Visual acuity in Foxg1
+/Cre 
 mice and wild-type littermates  
(A) Examples of VEP waveforms recorded in response to 0.1 c/deg gratings. (B) VEP amplitude 
changes in response to gratings of high contrast and of decreasing bar size (increasing spatial 
frequency) in a wild-type (WT) and a Foxg1
+/Cre 
mouse. VEP amplitude decreases by progressively 
increasing the spatial frequency. Visual acuity was determined by linearly extrapolating VEP 
amplitude to 0 V. Symbols represent data average data from all animals (WT n=9; Foxg1
+/Cre 
n=5). 
Arrows in the abscissa point to visual acuity value. Dotted line represents average noise level. (C) 
Spatial resolution in the visual cortex of wild-type and Foxg1
+/Cre
mice. Visual acuity is significantly 
reduced in Foxg1
+/Cre
mice compared with wild-type littermates (Foxg1
+/Cre
, 0.20 cycle/degree SEM 
0.05, n=9; WT, 0.51 cycle/degree, SEM 0.05 n=5; *, P,0.01, Student’s t test).  
 
Figure 2. Retinal morphology  in Foxg1
+/Cre
 animals and wild-type littermates 
Retinal morphology in Foxg1
+/Cre
 (A and C) and wt (B and D) mice. A, B: Low magnification 
images of retinal sections stained with rhodopsin antibodies (green signal), showing normal retinal 
laminations and bright staining of photoreceptor outer segments (OS) in both mutant and wt mice. 
Red: nuclear counterstaining. In A the normal morphology of the optic nerve head (ONH) can be 
appreciated. The insets show at 2x details of photoreceptor rows and outer segments. Here and in 
the following images: ONL, IPL outer nuclear and inner plexiform layer, respectively. C and D: 
examples of retinal ganglion cells (GC) stained by the type specific transcription factor Brn3-B 
(red), with nuclear localization, and by neurofilament antibodies (green), depicting their 
morphology in detail. 
 
Figure 3. Morphology of neuronal subtypes in Foxg1
+/Cre
 mice and wild-type littermates  
Morphology of retinal neuronal subtypes in Foxg1
+/Cre
 (left panels) and wt mice 
Retinal neurons in Foxg1
+/Cre
 (left panels) and wt mice. A, B: rod bipolar cells have been labelled 
red by PKC antibodies. Their dendrites form dense plexa in the OPL while axonal endings (rbe) 
cluster in regularly in the deepest part of the IPL. Green puncta are synaptic ribbons from 
glutamatergic processes, regularly arranged in the two plexiform layers. Blue: 
nuclearcounterstaining. C,D: types of cone bipolar cells stained by ZnP-1 (synaptotagmin 
antibodies). Both dendritic tips in the OPL and axonal arbors in the IPL have the expected fine 
structure. The IPL show three typical bands, revealed by calretinin staining of amacrine cells (red). 



































































symmetric populations at the two margins of the IPL. Alpha-like ganglion cells, labelled by SMI-32 
antibodies (green) have well preserved morphologies in both mutant and wt retinas. 
 





A,B. Cells in the GCL have been labelled by antibodies against the RNA binding protein RBPMS 
that produce a cytoplasmic staining in GCs selectively (green signal). Ethidium counterstaining (red 
signal) show the nuclei of GCs and displaced amacrine cells (AC).The general morphology (A and 





(B) mice. Quantification in C. The number of GCs proper (D) is also not different 
between the two strains (D). 
 





Panel A. A significant reduction of NeuN staining is present in layer II-III and IV of the visual 
cortex of Foxg1
+/Cre 
mice (WT: n=4; Foxg1
+/Cre
= n=4; two-ways RM ANOVA genotype X cortical 
layer p=0.003; post-hoc Sidak wt vs. Foxg1
+/Cre
 within layer II-III p=0.004, within layer IV 
p=0.006).  
Panel B. Calretinin positive cells in visual cortices from WT and Foxg1
+/Cre
 mice. Quantification of 
calretinin positive cells density in visual cortical layers of WT and Foxg1
+/Cre
 mice shows a 
significant increase of calretinin positive cells in layer II-III and VI of the Foxg1
+/Cre
 cortex (two-
ways RM ANOVA genotype X cortical layer p=0.04; post-hoc Sidak wt vs. Foxg1
+/Cre
 within layer 
II-III p<0.01, within layer VI p<0.05). 
Panel C Parvalbumin positive cells in visual cortices from WT and Foxg1
+/Cre 
mice. Quantification 
of parvalbumin positive cells density in visual cortical layers of WT and Foxg1
+/Cre
 mice shows a 
significant decrease of parvalbumin positive cells in layer II-III of the Foxg1
+/Cre
 cortex (two-ways 
RM ANOVA genotype X cortical layer p=0.03; post-hoc Sidak wt vs. Foxg1
+/Cre
 within layer II-III 
p<0.01).  
Panel D  GAD67 positive cells in visual cortices from WT and Foxg1
+/Cre 
mice. Quantification of 
GAD67 positive cells density in visual cortical layers of WT and Foxg1
+/Cre
 mice shows that the 
density of GAD67 positive cells is not statistically different between wt and Foxg1
+/Cre
 mice (two-
ways RM ANOVA effect of genotype p=0.44, genotype X cortical layer p=0.33)..*: p<0.05; **: 
p<0.01. 
 
Figure 6. Dendritic spine length and density in Foxg1
+/Cre



































































 A) Confocal microscope images of WT and Foxg1
+/Cre
dendritic segment. Scale bar= 5μm. B and 
C) Average dendritic spine length and density (respectively) in basal dendrites of layer 4/5 
pyramidal cells of Foxg1
+/Cre
and WT mice. A significant  decrease in spine density was measured 
in Foxg1
+/Cre
 as compared to wt mice (WT: n= 7; Foxg1
+/Cre
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NE: not evaluated  
^This case corresponds to Patient 1 in Ariani et al (1) 
L: Latency of the first positive inflection peak, normally close to 100 ms after stimulus onset (range between 90-105 ms in normal controls)  
A: Amplitude of the main positive peak (N75-P100) after the stimulus onset, ranged between 5.3 to 10 µV in normal controls 
Table 1
